Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,39305,0.0257029316605634,0.0089630993329843,0.00813525696791421,0.0432706063532127,0.00413767310331663
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,34284,0.0237300858738395,0.0100913690384301,0.00395100255851644,0.0435091691891625,0.0187023660480468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1070.Time spent watching television (TV),41388,0.00715828974665704,0.00898354171847543,-0.0104494520215548,0.0247660315148689,0.425558596324759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1080.Time spent using computer,34303,-0.0233821470992553,0.00931660326157151,-0.0416426894919355,-0.00512160470657514,0.012086962754493
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1090.Time spent driving,29783,0.0106050288574418,0.0102309022819911,-0.00944753961526083,0.0306575973301444,0.299945519144099
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1160.Sleep duration,43580,-0.00255359013482045,0.00820087200501697,-0.0186272992646537,0.0135201189950128,0.755513004419321
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,14214,0.0472356474122049,0.0303287443513147,-0.012208691516372,0.106679986340782,0.119384837746949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,14214,0.058654100810503,0.0295454471290778,0.000745024437510428,0.116563177183495,0.0471396268076986
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,14214,-0.0267144857213575,0.0334659039643159,-0.0923076574914166,0.0388786860487016,0.424733092267358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,14214,0.0118421098654187,0.0342385140242565,-0.055265377622124,0.0789495973529615,0.72944477048854
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,14214,-0.0204494908407074,0.0347205468191351,-0.0885017626062122,0.0476027809247974,0.555888248261365
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,14214,-0.0935470679707463,0.0743912450550223,-0.23935390827859,0.0522597723370974,0.208592943149216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,14214,0.0218153654849738,0.07620420632112,-0.127544878904421,0.171175609874369,0.774671617029187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,14214,-0.0317965850200503,0.0531796083618234,-0.136028617409224,0.0724354473691236,0.549909956601364
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,14214,-0.012575832614116,0.0393044130259196,-0.0896124821449184,0.0644608169166864,0.749003502891146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,14214,0.0410049135876217,0.0266945975219831,-0.0113164975554652,0.0933263247307087,0.124542177701533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,14214,0.103268894911694,0.0386153396696831,0.0275828291591149,0.178954960664273,0.00749717881913208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,14214,-0.00645891124081316,0.021659267479666,-0.0489110755009585,0.0359932530193322,0.765550738341523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,14214,0.00512264550271523,0.0278087296623302,-0.049382464635452,0.0596277556408825,0.853851361876935
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,14214,0.0770197073772105,0.0410961187480644,-0.00352868536899573,0.157568100123417,0.0609322265022887
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,14214,0.0081352814144018,0.0385411070037108,-0.0674052883128714,0.083675851141675,0.832827378274415
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,14214,-0.0100408994851449,0.0513820074594322,-0.110749634105632,0.0906678351353422,0.845069583343842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,14214,0.0325803286210073,0.0494201334589625,-0.0642831329585591,0.129443790200574,0.509744562225831
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,14214,0.00119694126952552,0.0302810325016282,-0.0581538824336657,0.0605477649727167,0.968470180260142
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,14214,-0.0205891344075585,0.0285962389769424,-0.0766377628023656,0.0354594939872486,0.471540240394673
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,14214,0.00178801675593511,0.0357506823235873,-0.068283320598296,0.0718593541101662,0.960112333641246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120040.Fatigue severity over the past week,14228,-0.00028568723107291,0.014601029136661,-0.0289037043389285,0.0283323298767826,0.984389670428397
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,14229,-0.00532126734861161,0.014461476390522,-0.0336657610740347,0.0230232263768115,0.712907379824784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,14227,0.014624884381992,0.0156700960293733,-0.0160885038355797,0.0453382725995638,0.350681486709456
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120098.Mobility problems today,14235,-0.042522453557151,0.0171182155692411,-0.0760741560728636,-0.00897075104143831,0.0130012895671952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120099.Self-care problems today,14235,-0.05581038608916,0.0264894547805911,-0.107729717459119,-0.00389105471920142,0.0351445251257817
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120100.Problems doing usual activities,14235,-0.00889037935012231,0.0163190341473746,-0.0408756862789765,0.0230949275787319,0.585909336743041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120101.Pain or discomfort today,14235,0.00397483304675622,0.0145453569454896,-0.0245340665664033,0.0324837326599158,0.784648409480616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120102.Anxiety or depression today,14235,0.012695636219073,0.0176885553321157,-0.0219739322318738,0.0473652046700198,0.472934548860301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120103.Scale to indicate how health is today,14184,0.0166578311114154,0.00934306572152996,-0.00165457770278332,0.0349702399256141,0.0746226031092117
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,14197,-0.0217529782722505,0.0179132855990166,-0.056863018046323,0.0133570615018219,0.224634749323717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",14172,-0.00433754912534732,0.0183775906004387,-0.0403576267022073,0.0316825284515126,0.813417601615947
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",14207,0.0068075350780456,0.0145111356280268,-0.0216342907528869,0.0352493609089781,0.638987567391711
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,14212,-0.00616621133750299,0.0148399105854889,-0.0352524360850613,0.0229200134100553,0.677770926397224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,14216,-0.0201492182981991,0.0192323641070619,-0.0578446519480403,0.0175462153516422,0.294807369900213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,14176,-0.00283205703736364,0.0193160610008017,-0.0406915365989349,0.0350274225242077,0.883436662065617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,14215,-0.0240959267543534,0.0194081516251534,-0.062135903939654,0.0139440504309471,0.214428167590441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,14200,-0.0539123259456131,0.0287617294578797,-0.110285315683057,0.00246066379183123,0.0608894321811071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,14135,-0.0100074729294741,0.0388242896668444,-0.0861030806764891,0.066088134817541,0.796593427986849
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",9888,-0.00903563807983704,0.0198496231723985,-0.047940899497738,0.029869623338064,0.648972123604106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,39346,0.0186767298922473,0.0199456636269305,-0.0204167708165365,0.0577702306010312,0.349083078778848
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,36718,0.0237788221076155,0.0121929381804906,-0.00011933672614613,0.0476769809413772,0.0511583823000049
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1289.Cooked vegetable intake,42300,-0.00109486922788048,0.00857818157911688,-0.0179081051229496,0.0157183666671886,0.898439082364317
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,41172,-0.023339456971475,0.00907097679543307,-0.0411185714905238,-0.00556034245242614,0.0100861247348043
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1309.Fresh fruit intake,42247,-0.00669436221865362,0.00897188024969003,-0.0242792475080461,0.0108905230707388,0.455581380776897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1319.Dried fruit intake,39930,-0.00414805241633971,0.00922039127204592,-0.0222200193095497,0.0139239144768703,0.652800758306301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X134.Number of self-reported cancers,43958,-0.0370102951832543,0.0160320760288276,-0.0684331641997564,-0.00558742616675219,0.020975102873645
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,43959,0.00796079245387391,0.00851339613248641,-0.00872546396579946,0.0246470488735473,0.349747005630132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X136.Number of operations, self-reported",43959,-0.00196806973748796,0.00840414016995933,-0.0184401844706082,0.0145040449956323,0.814847422683577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X137.Number of treatments or medications taken,43959,-0.00461658584022496,0.00834546782404153,-0.0209737027753464,0.0117405310948964,0.580139697206937
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1438.Bread intake,42680,0.00675220958090133,0.00551776690677099,-0.0040626135563698,0.0175670327181725,0.22106409236528
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1458.Cereal intake,41730,0.00200639928348318,0.00852069086098342,-0.0146941548040443,0.0187069533710107,0.813842183363483
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1488.Tea intake,42406,-0.00444452008211814,0.0052828607721969,-0.0147989271956241,0.00590988703138779,0.400179408063652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1498.Coffee intake,40534,0.024075344475122,0.00856056050195101,0.00729664589129803,0.040854043058946,0.0049203667248166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1528.Water intake,40703,-0.0111547383197565,0.00871912770134671,-0.028244228614396,0.00593475197488307,0.200784265065951
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1568.Average weekly red wine intake,29889,-0.0195358918417406,0.00986833506826418,-0.0388778285755384,-0.000193955107942796,0.0477515516234198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,29883,-0.00359345100274609,0.0100993135167235,-0.0233881054955242,0.016201203490032,0.721984314993385
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,29963,-0.0149036278459294,0.0112512044614964,-0.0369559885904624,0.00714873289860361,0.185305633999035
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1598.Average weekly spirits intake,29841,-0.00445329720667379,0.0109163919143969,-0.0258494253588918,0.0169428309455442,0.683316329715598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,29940,0.0575073071285443,0.0179449510183712,0.0223352031325368,0.0926794111245518,0.00135368069324572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,32933,-0.0334034297384273,0.0101679917977371,-0.053332693661992,-0.0134741658148626,0.00102032730105275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1807.Father's age at death,32469,0.006494680659931,0.00606953137471075,-0.00540160083450207,0.0183909621543641,0.284606347122391
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1845.Mother's age,16692,0.0158198692586441,0.0140382790901623,-0.0116951577580741,0.0433348962753622,0.259796984001411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1873.Number of full brothers,43168,0.0118063696350582,0.00825652310960613,-0.00437641565976977,0.0279891549298863,0.152740194579407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1883.Number of full sisters,43173,0.0123375985370842,0.00827077400214753,-0.003873118507125,0.0285483155812933,0.135782424138536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20015.Sitting height,43614,-0.018005891665833,0.00694197997273418,-0.031612172412392,-0.00439961091927405,0.00949620092740804
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20016.Fluid intelligence score,14289,0.000609960083144339,0.0135314641162095,-0.0259117095846263,0.027131629750915,0.964046431152507
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20018.Prospective memory result,14878,0.00713859173566129,0.0180662678821866,-0.0282712933134244,0.042548476784747,0.692749870793858
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),14087,-0.010609237723658,0.0095187430783147,-0.0292659741571548,0.00804749870983879,0.265056817243041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),14074,-0.0024332368289488,0.00949365135476975,-0.0210407934842975,0.0161743198263999,0.797721809537767
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20023.Mean time to correctly identify matches,43434,-0.00103491680874163,0.00559133431304731,-0.0119939320623144,0.00992409844483109,0.853156961111227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,38262,0.00485727917331782,0.0119263735097485,-0.0185184129057892,0.0282329712524248,0.68381043184058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,37524,-0.0599296793581403,0.0261614344942249,-0.111206090966821,-0.00865326774945945,0.0219825712847523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,37463,-0.0131099333445337,0.0351594456244579,-0.0820224467684712,0.0558025800794037,0.709246658095585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,37498,0.0325356988674245,0.0295702402486838,-0.0254219720199957,0.0904933697548447,0.271214927296346
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,37527,0.0401666889793032,0.0210943725121013,-0.00117828114441541,0.0815116591030218,0.0568992846402279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,37802,-0.0020042637567468,0.0153403936597003,-0.0320714353297594,0.0280629078162658,0.896050751756438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,37709,-0.0157482953587906,0.0194054755746973,-0.0537830274851973,0.0222864367676161,0.417061474438171
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,37535,-0.0539888497054138,0.0242277651081225,-0.101475269317334,-0.00650243009349365,0.0258605855266886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,37795,0.0125538990497364,0.017741574437815,-0.022219586848381,0.0473273849478538,0.479199423877501
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,37903,0.00967764533044101,0.0133953011678883,-0.0165771449586201,0.0359324356195021,0.470012679196498
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,37667,0.00516110263557349,0.018498156623157,-0.0310952843458142,0.0414174896169612,0.780241505717386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,40054,-0.00203144847944282,0.0136314667288114,-0.0287491232679131,0.0246862263090274,0.881533548079518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,39812,0.0255995708244341,0.019605451758336,-0.0128271146219045,0.0640262562707727,0.191649435859005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,39686,-0.0200415900696646,0.0432465123228507,-0.104804754222452,0.0647215740831227,0.643061060287516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,39749,0.0581594348519454,0.0219258330206269,0.0151848021315166,0.101134067572374,0.00799173167871539
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,39953,0.00921990263744537,0.0155509263288272,-0.0212599129670559,0.0396997182419466,0.553261832181151
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,39767,-0.032299900365421,0.0275584174925123,-0.0863143986507452,0.0217145979199032,0.241183174011889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,39735,0.01475151058816,0.0245772036830748,-0.0334198086306666,0.0629228298069866,0.548368977600129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,39769,0.00751227621233122,0.0201408466512165,-0.031963783224053,0.0469883356487155,0.709160025153201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,39817,0.0117499439652619,0.0230196582211449,-0.0333685861481821,0.0568684740787059,0.609752471376241
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,40141,-0.00679537081873248,0.0117953595828273,-0.029914275601074,0.016323533963609,0.564547145928857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,39880,0.0131954356307356,0.0182183550785105,-0.0225125403231451,0.0489034115846162,0.468889835036028
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,34405,-0.0203338375444004,0.019107130059649,-0.0577838124613124,0.0171161373725116,0.287244873994484
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,34153,-0.046713657109605,0.0763170167914457,-0.196295010020839,0.102867695801629,0.540475577568985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,34147,0.0424013901533832,0.0770139539755646,-0.108545959638723,0.19334873994549,0.581933706712439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,34253,-0.0116229332927403,0.0226286914059776,-0.0559751684484564,0.0327293018629758,0.607509116528322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,34170,0.0146044690767221,0.0447877623680899,-0.0731795451647341,0.102388483318178,0.744364550384485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,34215,-0.0213896452335071,0.0320973819223873,-0.0843005138013861,0.041521223334372,0.50516095455893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,34172,0.0739448263159795,0.0380821410257742,-0.000696170094537832,0.148585822726497,0.0521793083925915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,34176,0.00424760198217416,0.0373880563133827,-0.0690329883920559,0.0775281923564043,0.909548795634213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,34197,-0.0339310896947517,0.0279559816556295,-0.0887248137397855,0.0208626343502821,0.224858190826717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,34219,-0.0112697294486546,0.0347595243596449,-0.0793983971935585,0.0568589382962494,0.745773540974253
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,34521,0.00223223874195824,0.0142908146604895,-0.0257777579926011,0.0302422354765176,0.875875546331449
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,34336,-0.00513672751375473,0.0201840691448539,-0.0446975030376684,0.034424048010159,0.799115347904397
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20127.Neuroticism score,34906,0.00499095924909886,0.00861121798120829,-0.0118870279940694,0.0218689464922671,0.562196180206373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,14289,0.0105474550287395,0.0137219266616486,-0.0163475212280918,0.0374424312855709,0.442109681991217
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20161.Pack years of smoking,13513,-0.00276903367278194,0.0100502392858572,-0.0224675026730621,0.0169294353274982,0.782921610533617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,13513,-0.00206344929117036,0.00990688401345219,-0.0214809419575366,0.0173540433751959,0.835010061883678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20191.Fluid intelligence score,10598,0.037063276341418,0.015822307771881,0.00605155310853134,0.0680749995743047,0.0191750400302788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,10599,0.0348495198814167,0.0161675643017885,0.00316109384991121,0.0665379459129222,0.0311436049842921
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20240.Maximum digits remembered correctly,9513,0.00375010022853234,0.0169806173616936,-0.029531909800387,0.0370321102574517,0.825217150184857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20255.Spirometry QC measure,32604,0.0389992265090859,0.0109826570039101,0.017473218781422,0.0605252342367497,0.00038433625358269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20261.avMSE,9779,-0.0281833723610049,0.0111615586876486,-0.0500600273887962,-0.00630671733321366,0.0115842413137079
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20262.Myopia diagnosis,9779,0.0237357802356792,0.0206544545971043,-0.0167469507746452,0.0642185112460036,0.250508036887508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20280.Glucose-lactate,24386,0.0923498969470463,0.00714726578057319,0.0783412560171228,0.10635853787697,4.56969069722887e-38
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,24436,0.0933787748361159,0.00717822900705138,0.0793094459822952,0.107448103689937,1.46857437881365e-38
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,13700,0.0340702281364721,0.0374178695421022,-0.0392687961660481,0.107409252438992,0.36255719653708
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,13698,0.0229796023797582,0.0732913613162656,-0.120671465800122,0.166630670559639,0.753876987641549
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),13699,0.0243832602144308,0.0917430335106871,-0.155433085466516,0.204199605895377,0.790414356873003
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),13699,0.0479469258726368,0.0355874811255727,-0.0218045371334857,0.117698388878759,0.177906729816789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),13699,0.057777590923805,0.0613340509948675,-0.0624371490261353,0.177992330873745,0.346201631555772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,13706,0.0522351861936877,0.0787898261939503,-0.102192873146455,0.20666324553383,0.507361780824037
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,13706,0.0455013830562102,0.0520379439249059,-0.0564929870366055,0.147495753149026,0.381922019640262
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,13706,0.00497511626814571,0.0579198747183952,-0.108547838179909,0.1184980707162,0.93154992577248
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,13706,0.026206724350495,0.0898205040322497,-0.149841463552714,0.202254912253704,0.770468641982215
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,13706,0.0445815134834215,0.103582833581112,-0.158440840335558,0.247603867302401,0.666915247709294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,13706,-0.0223451306049667,0.0611914632920794,-0.142280398657442,0.097590137447509,0.714992054625771
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,13706,0.119045732583733,0.102679261148141,-0.0822056192666241,0.32029708443409,0.246315786783259
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,13706,0.0251486211156762,0.0755973552649898,-0.123022195203704,0.173319437435056,0.739391996152029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),13709,0.131712067857065,0.104944931210635,-0.0739799973157794,0.33740413302991,0.209478802036973
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),13709,0.0344578316031622,0.0479305224789005,-0.0594859924554828,0.128401655661807,0.472207358844379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),13709,0.0538909660962565,0.0712071148130587,-0.0856749789373386,0.193456911129851,0.449170749826575
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,13710,0.183203566607838,0.122736155808665,-0.0573592987771463,0.423766431992821,0.135548781310817
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,15511,-0.00745002022875548,0.0129236926534348,-0.0327804578294877,0.0178804173719767,0.564311193408035
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20601.Liking for aniseed,15511,0.010480286736689,0.0128547378163747,-0.0147149993834054,0.0356755728567835,0.414921203607266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20602.Liking for apple juice,15511,0.0319191795663831,0.0128987671908688,0.0066375958722802,0.057200763260486,0.013349492438827
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20603.Liking for apples,15511,-0.000469977536666532,0.0131816400482958,-0.0263059920313263,0.0253660369579933,0.971558749150121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20604.Liking for asparagus,15511,-0.00531961001434483,0.0131146749829034,-0.0310243729808355,0.0203851529521458,0.685025442479562
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20605.Liking for aubergine,15511,-0.023288647943927,0.0129718122443315,-0.0487133999428167,0.00213610405496268,0.0726210644318339
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20606.Liking for avocados,15511,0.00770037383426343,0.0130805206948815,-0.0179374467277042,0.0333381943962311,0.556077724229948
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20607.Liking for bacon,15511,0.00184410153047566,0.0130432402401786,-0.0237206493402744,0.0274088524012258,0.887568671339301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,15511,0.00168918779940315,0.0131310440907403,-0.0240476586184478,0.0274260342172541,0.897643564172163
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20609.Liking for bananas,15511,0.0129163086073974,0.0134191842446953,-0.0133852925122054,0.0392179097270002,0.335800668068272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,15511,-0.0265705606879329,0.013033392738751,-0.0521160104558849,-0.00102511091998084,0.0415016527182822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20611.Liking for beef steak,15511,-0.00768987384036983,0.0130496228865722,-0.0332671346980513,0.0178873870173117,0.555682461793675
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20612.Liking for beetroot,15511,0.0101616060870662,0.0131893790901033,-0.0156895769295364,0.0360127891036687,0.44105154558775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20613.Liking for bell pepper,15511,-0.014427197794353,0.0130283632038,-0.039962789673801,0.0111083940850949,0.26815187735861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20614.Liking for bicycling,15511,0.0252770399681279,0.0129504768687202,-0.000105894694563739,0.0506599746308195,0.0509772071219684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20615.Liking for biscuits,15511,0.0290072813233793,0.0130417662189352,0.00344541953426634,0.0545691431124922,0.0261504604262542
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20616.Liking for bitter foods,15511,-0.0217799830182563,0.0129286644972435,-0.0471201654328535,0.00356019939634084,0.0920806211117716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20617.Liking for bitter or ale,15511,-0.00148857126690024,0.0132644811612767,-0.0274869543430025,0.0245098118092021,0.910648561528233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20618.Liking for black olives,15511,-0.00499559041828213,0.013004571184857,-0.0304845499406019,0.0204933691040377,0.700879136323809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20619.Liking for black pepper,15511,-0.0037208620351309,0.0131024236218789,-0.0294016123340135,0.0219598882637517,0.77642741134359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20620.Liking for blue cheese,15511,0.0240405847570822,0.0129451944102333,-0.00133199628697506,0.0494131658011394,0.0633151925740212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,15511,-0.00905480604379922,0.0130770189948071,-0.0346857632736211,0.0165761511860227,0.488683195871604
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20622.Liking for broad beans,15511,0.00663405719049953,0.0129692992921074,-0.018785769422031,0.03205388380303,0.608994214189524
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20623.Liking for broccoli,15511,0.00953992260630503,0.0133434695127232,-0.0166132776386324,0.0356931228512424,0.47465029545717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20624.Liking for brown rice,15511,-0.000399014279651311,0.0129991705746512,-0.0258773886059677,0.0250793600466651,0.975512883485371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,15511,0.0220872235895207,0.0131220488941227,-0.00363199224295971,0.0478064394220012,0.0923537196672205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20626.Liking for burgers (meat),15511,-0.0246276885859103,0.0129590971431644,-0.0500275189865125,0.00077214181469204,0.0573969670725198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,15511,-0.0260844283873169,0.0129674737990248,-0.0515006770334054,-0.000668179741228306,0.0442870716782028
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20628.Liking for butter on bread,15511,0.0237275282666359,0.0131708023093158,-0.00208724425962308,0.0495423007928948,0.0716396272703854
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20629.Liking for butternut squash,15511,-0.0169305452266552,0.0129336156543067,-0.0422804319090963,0.00841934145578593,0.190542187087005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20630.Liking for cabbage,15511,0.00329323156261382,0.0131043627754977,-0.0223913194773617,0.0289777826025893,0.801579303161034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20631.Liking for cake,15511,0.0170550218864834,0.0130796420320464,-0.00858107649632757,0.0426911202692943,0.192274633080023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20632.Liking for cake icing,15511,0.0110939223672093,0.0128741307740122,-0.0141393739498546,0.0363272186842732,0.388853829538379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20633.Liking for capers,15511,-0.0146528835604846,0.0129300907843566,-0.0399958614978235,0.0106900943768544,0.257131428862014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20634.Liking for cauliflower,15511,0.00411968191501417,0.0131923045300225,-0.02173723496383,0.0299765987938584,0.754832572627612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,15511,0.0102721758457005,0.0129291269922681,-0.0150689130591449,0.0356132647505458,0.426917282388344
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20636.Liking for cheesecake,15511,0.0465843534460115,0.0129944446554947,0.0211152419212419,0.072053464970781,0.00033818733567667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20637.Liking for cherries,15511,0.0141997319138442,0.0136586090134133,-0.0125711417524459,0.0409706055801343,0.298533771455216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20638.Liking for chicken,15511,-0.0177569484239469,0.0135918517600718,-0.0443969778736877,0.00888308102579384,0.19142213006568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20639.Liking for chilli pepper,15511,-0.0294835435070463,0.0129650489016891,-0.054895039354357,-0.00407204765973558,0.0229748652323186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20640.Liking for chips or french fries,15511,0.00142718289793019,0.0130286644619291,-0.0241089994474509,0.0269633652433113,0.912774216724166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,15511,-0.0275156882600244,0.0210570012448672,-0.0687874106999641,0.0137560341799154,0.191325877006915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20642.Liking for cod,15511,0.00879179762800262,0.0133675264095635,-0.0174085541347419,0.0349921493907472,0.510741874313784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,15511,0.00553557748513656,0.0141973215162748,-0.022291172686762,0.0333623276570351,0.696613676866335
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,15511,0.010821457738398,0.0132027994845332,-0.015056029251287,0.0366989447280831,0.412437640141738
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20645.Liking for coriander,15511,-0.00504754237201145,0.0129737147495255,-0.0304760232810815,0.0203809385370586,0.697237743143823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20646.Liking for corn flakes,15511,0.0127065998953624,0.012965242431757,-0.0127052752708813,0.0381184750616061,0.327076211590742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20647.Liking for cream,15511,0.0231480416480814,0.0129473289441847,-0.00222872308252064,0.0485248063786834,0.0738177658201705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20648.Liking for croissant,15511,0.0116272851023719,0.0129684174430134,-0.0137908130859345,0.0370453832906782,0.369954482452518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20649.Liking for cucumber,15511,-0.00327576144189824,0.0130521544568572,-0.0288579841773383,0.0223064612935419,0.801836946243884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20650.Liking for curry,15511,-0.0283672896134634,0.0131339925137282,-0.0541099149403707,-0.00262466428655602,0.0308005463279976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20651.Liking for dairy products,15511,0.0442605793161268,0.0132017388336244,0.0183851712022229,0.0701359874300306,0.000802385954000921
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20652.Liking for dark chocolate,15511,0.0126738247616726,0.0131348476271099,-0.0130704765874628,0.0384181261108081,0.334609574498996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,15511,0.00533949856044822,0.0134113499203562,-0.0209467472834499,0.0316257444043463,0.690537770817952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20654.Liking for dried fruit,15511,0.00966125433858708,0.0130887531259821,-0.0159927017883377,0.0353152104655119,0.460444178668836
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20655.Liking for eggs,15511,0.00871907588196796,0.0133858713258945,-0.0175172319167853,0.0349553836807212,0.514821150526152
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20656.Liking for exercising alone,15511,0.0245587039659722,0.0129721195927952,-0.000866650435906478,0.0499840583678509,0.0583510570388366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20657.Liking for exercising with others,15511,0.031127820414721,0.0129682098141606,0.00571012917896619,0.0565455116504757,0.0163925846928411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,15511,-0.00903039768102087,0.013126149978331,-0.0347576516385496,0.0166968562765078,0.491481963045292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20659.Liking for fatty foods,15511,-0.0172758104284415,0.0129988272894579,-0.042753511915779,0.00820189105889601,0.183858183370221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,15511,0.00786739422109969,0.0138987932433086,-0.0193742405357852,0.0351090289779846,0.571368857832617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20661.Liking for fried chicken,15511,-0.00911208794684839,0.0129022443008673,-0.0344004867765483,0.0161763108828515,0.480049188363217
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,15511,0.00509396889595492,0.0130082528252825,-0.0204022066415987,0.0305901444335085,0.695362749219069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20663.Liking for fruit,15511,0.0277348228449147,0.0144884986522659,-0.00066263451352647,0.0561322802033558,0.0556047374814392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20664.Liking for garlic,15511,-0.0195934398386586,0.0131510002715386,-0.0453694003708742,0.00618252069355696,0.136275603116686
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20665.Liking for gherkins,15511,-0.00755729750906635,0.0128755914064077,-0.0327934566656254,0.0176788616474927,0.557247453148226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20666.Liking for globe artichoke,15511,-0.00146563160541684,0.0130087099394931,-0.0269627030868234,0.0240314398759897,0.910297287593343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20667.Liking for goat's cheese,15511,0.00712616414343647,0.0129431620897661,-0.018242433552505,0.032494761839378,0.581933908992306
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20668.Liking for going to a cafe,15511,-0.000372375583377206,0.0130564051932282,-0.0259629297621045,0.0252181785953501,0.977247362352128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20669.Liking for going to the gym,15511,0.0121379904502083,0.0128829203263377,-0.0131125333894135,0.0373885142898302,0.346116753506743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20670.Liking for going to the pub,15511,-0.00329311400609069,0.0129701586780916,-0.0287146250151503,0.0221283970029689,0.799576738050089
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20671.Liking for grapefruit,15511,0.0155134331992697,0.0129308956032549,-0.00983112218310986,0.0408579885816493,0.230267081937651
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20672.Liking for green olives,15511,0.00133080957140316,0.0130033362882739,-0.0241557295536137,0.0268173486964201,0.918485193311529
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20673.Liking for haddock,15511,-0.00954367064275782,0.0132748439692922,-0.0355623648225706,0.0164750235370549,0.472195497393382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20674.Liking for ham,15511,0.0114013453415102,0.0130593693351572,-0.0141950185553979,0.0369977092384182,0.382655080341814
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20675.Liking for hard cheese,15511,0.0329884142404292,0.0132950447467448,0.00693012653680947,0.059046701944049,0.0131025481182749
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20676.Liking for herring,15511,0.00921766033169626,0.0128976174940374,-0.016061669956617,0.0344969906200095,0.474817998661547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20677.Liking for honey,15511,0.0154349570650736,0.0129788562798076,-0.0100036012433493,0.0408735153734965,0.234364014863426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,15511,-0.014004465203985,0.0129246239652034,-0.0393367281757835,0.0113277977678136,0.278581618601352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20679.Liking for ice cream,15511,0.0230786547777669,0.0130313193934025,-0.002462731233302,0.0486200407888358,0.0765779644704362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20680.Liking for jam,15511,0.0330239093912368,0.0129791372933831,0.00758480029620592,0.0584630184862677,0.010956689044267
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,15511,0.00885513149884382,0.0130046743633875,-0.0166340302533957,0.0343442932510834,0.495932845032118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20682.Liking for lager,15511,-0.0341451935952557,0.0130594088399524,-0.0597416349215623,-0.00854875226894909,0.00894172421193977
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20683.Liking for lamb,15511,-0.000342347925857766,0.0131602001254654,-0.02613634017177,0.0254516443200545,0.979246599127324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20684.Liking for lemons,15511,-0.00859157435304487,0.0130226768968514,-0.0341160210708735,0.0169328723647838,0.509430823289279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20685.Liking for lentils or beans,15511,-0.0109444728922509,0.0130879482662447,-0.0365968514940904,0.0147079057095887,0.403041093450095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20686.Liking for liver,15511,0.0343067585254885,0.0129699502820653,0.00888565597264043,0.0597278610783366,0.00817502606607425
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20687.Liking for mackerel,15511,0.00272341591865272,0.0129453638714032,-0.0226494972692975,0.028096329106603,0.833375660943464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20688.Liking for marzipan,15511,0.0138642372870903,0.0128954696023926,-0.0114108831335992,0.0391393577077798,0.282335671221025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20689.Liking for mayonnaise,15511,-0.00671879411779592,0.0129728915402627,-0.0321456615367109,0.018708073301119,0.604528254519842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20690.Liking for melon,15511,-0.00015523483642014,0.0134162955384811,-0.0264511740918431,0.0261407044190028,0.99076833721514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20691.Liking for milk chocolate,15511,0.0251894654914654,0.0130850941034711,-0.000457318951338066,0.0508362499342688,0.0542413467192783
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20692.Liking for mushrooms,15511,0.00859698334179298,0.0133779966847965,-0.0176238901604081,0.034817856843994,0.520479481604769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20694.Liking for orange juice,15511,0.0118196443993425,0.0129863104212009,-0.0136335240262114,0.0372728128248963,0.362751320842071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20695.Liking for oranges,15511,-0.00332966641876722,0.0132190197611798,-0.0292389451506797,0.0225796123131452,0.801133668934126
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20696.Liking for pasta,15511,0.00142633569703459,0.0131058399760512,-0.0242611106560257,0.0271137820500949,0.913337096377499
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20697.Liking for pears,15511,0.0180042027702378,0.0132397177544453,-0.00794564402847507,0.0439540495689507,0.173893064932568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20698.Liking for pizza,15511,-0.0179426858829757,0.0129831942495586,-0.0433897466121105,0.00750437484615904,0.16699372688911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20699.Liking for plain yogurt,15511,0.016800494118347,0.0130138923045701,-0.00870673479861049,0.0423077230353044,0.196734692905395
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20700.Liking for plums,15511,0.0115056917817133,0.0132526089829339,-0.0144694218248371,0.0374808053882637,0.385307530208699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20701.Liking for pollock,15511,0.0086023451755352,0.0129376926719712,-0.0167555324615284,0.0339602228125988,0.50612073083908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20702.Liking for pork chop,15511,-0.00490907731691906,0.0129345135641515,-0.030260723902656,0.0204425692688179,0.704297159000448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20703.Liking for porridge,15511,0.0298689512559852,0.0132022012649451,0.00399263677669283,0.0557452657352775,0.0236851329997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20704.Liking for potato crisps,15511,0.00273153424068737,0.013043360524589,-0.022833452387507,0.0282965208688818,0.834123513727769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20705.Liking for potatoes,15511,0.00702315803317432,0.0131904057574532,-0.0188300372514339,0.0328763533177826,0.594425859763084
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20706.Liking for prawns,15511,-0.00937650312452037,0.0131469907578092,-0.0351446050098264,0.0163915987607857,0.475729489834641
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20707.Liking for raw carrots,15511,-0.00278242787226507,0.0130866900405525,-0.0284323403517479,0.0228674846072178,0.83162999306069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20708.Liking for red meat,15511,-0.0223261110208963,0.0130474472495696,-0.0478991076300527,0.0032468855882601,0.0870738500953439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20709.Liking for red wine,15511,-0.0074830681163163,0.0130669127680641,-0.0330942171417219,0.0181280809090893,0.566874436048491
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,15511,0.0222163622516714,0.0134010271034307,-0.00404965087105275,0.0484823753743955,0.0973759909988619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20711.Liking for roast chicken,15511,-0.00425427529701132,0.0136386891546574,-0.0309861060401398,0.0224775554461171,0.755100206637041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20712.Liking for salad dressing,15511,-0.0143148300534824,0.0130181764868,-0.0398304559676103,0.0112007958606456,0.271522087182448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20713.Liking for salad leaves,15511,-0.0105151816081582,0.013300447420588,-0.0365840585525106,0.0155536953361942,0.429196228307276
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20714.Liking for salami,15511,-0.0212481621605879,0.0129585101504168,-0.0466468420554047,0.00415051773422897,0.101086373724453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20715.Liking for salmon,15511,-0.0215126918845626,0.0135763367220948,-0.0481223118598685,0.00509692809074322,0.1130838790233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20716.Liking for salty foods,15511,0.00921385770985555,0.0128866699342901,-0.016044015361353,0.0344717307810641,0.474625156784224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20717.Liking for salty pretzels,15511,0.000428958545561748,0.0129320058459266,-0.0249177729124545,0.025775690003578,0.973539207708342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20718.Liking for sardines,15511,0.0174389099343426,0.0129117439886157,-0.00786810828334409,0.0427459281520293,0.176835675784482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20719.Liking for sausages (meat),15511,-0.000622290035922627,0.0129872771778124,-0.026077353304435,0.0248327732325897,0.961784317312347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,15511,0.0204140533361022,0.0130903596397314,-0.00524305155777138,0.0460711582299758,0.118905066100823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),15511,-0.00936247638243567,0.0129144350734666,-0.0346747691264302,0.0159498163615588,0.468486214369686
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20722.Liking for skimmed milk,15511,-0.00485174439385928,0.0129461932634422,-0.0302262831902059,0.0205227944024873,0.707842429811051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20723.Liking for smoked fish,15511,0.00272208927736358,0.0129666692327811,-0.0226925824188873,0.0281367609736145,0.833725284981089
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20724.Liking for soft cheese,15511,0.0365764326193248,0.0129590324613757,0.0111767289950284,0.0619761362436213,0.00477165570495871
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20725.Liking for soy sauce,15511,-0.0115113812183049,0.0129740658465947,-0.0369405502776305,0.0139177878410207,0.374952233691615
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20726.Liking for soya milk,15511,-0.00751510689055348,0.0130575760144323,-0.0331079558788407,0.0180777420977338,0.564937117883314
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20727.Liking for spicy foods,15511,-0.0282792789824709,0.0130081538005796,-0.0537752604316069,-0.00278329753333499,0.0297228106398813
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20728.Liking for spinach,15511,-0.00117571128974126,0.0130426465038249,-0.026739298437238,0.0243878758577555,0.928174257096384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20729.Liking for spirits,15511,0.00480781144708013,0.0129413112271595,-0.0205571585581525,0.0301727814523128,0.71026365921689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20730.Liking for strawberries,15511,0.00704241161984326,0.0141145464520715,-0.020622099426217,0.0347069226659035,0.61782375796272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,15511,0.0166344238601996,0.0132651881063293,-0.00936534482820582,0.042634192548605,0.209864275200946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20732.Liking for sweet foods,15511,0.0296598982921403,0.0129636514130033,0.00425114152265381,0.0550686550616268,0.0221551388093296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20733.Liking for taking the stairs,15511,0.0301537258256097,0.0132551727575353,0.00417358722084041,0.0561338644303789,0.0229276494038239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20734.Liking for tea with sugar,15511,0.00856744493864016,0.0157394057101727,-0.0222817902532984,0.0394166801305787,0.586221620479351
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20735.Liking for tea without sugar,15511,0.002391410320834,0.0136116479544266,-0.0242874196698422,0.0290702403115102,0.860540949404418
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,15511,0.0138993422552011,0.0129892236979627,-0.0115595361928058,0.0393582207032079,0.284605736565718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20737.Liking for tinned tuna,15511,0.00184496262629716,0.0130105346046657,-0.0236556851988476,0.0273456104514419,0.887235650263605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20738.Liking for turnip (white),15511,0.00615010526844772,0.0129447288142982,-0.0192215632075768,0.0315217737444722,0.634718840753789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20739.Liking for vegetables,15511,0.0263517470792869,0.0143343871600606,-0.00174365175443195,0.0544471459130058,0.066028686408162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20740.Liking for vinegar,15511,-0.0168337839122813,0.0129431148165464,-0.0422022889527121,0.00853472112814959,0.193415584238669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20741.Liking for watching television,15511,-0.0192334488105914,0.0130940065981045,-0.0448977017428762,0.0064308041216935,0.141887216271821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20742.Liking for whisky,15511,0.0133816793895892,0.0134385313039197,-0.0129578419660935,0.0397212007452718,0.319377716867681
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20743.Liking for white bread,15511,0.00271992441899115,0.0128901285759254,-0.0225447275898226,0.0279845764278049,0.832883552536755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20744.Liking for white rice,15511,-0.00302095302215573,0.013045681281972,-0.0285904883348209,0.0225485822905094,0.816877177197182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20745.Liking for white wine,15511,-0.00103995678925572,0.0129670191481936,-0.0264553143197152,0.0243754007412038,0.936079112677258
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,15511,0.0290992975438813,0.0130810360010064,0.00346046698190879,0.0547381281058537,0.0261264393528927
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20747.Liking for whole milk,15511,0.0244158200738216,0.0128684782359613,-0.000806397268662669,0.0496380374163058,0.0578022591563886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,15511,0.00902443654978344,0.0135483387584899,-0.0175303074168568,0.0355791805164237,0.505362383922441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20749.Liking for working up a sweat,15511,0.0138797610481757,0.0129878066420146,-0.011576339970173,0.0393358620665244,0.285232213386806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21001.Body mass index (BMI),43753,0.107385832380734,0.022814267363247,0.0626698683487698,0.152101796412698,2.52207843243888e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21002.Weight,43786,-0.0173152307499869,0.0129073954376885,-0.0426137258078563,0.00798326430788249,0.179766140643886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,14773,0.00366891266130125,0.00937210844596279,-0.0147004198927858,0.0220382452153883,0.695454456848634
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,14860,-0.0134933920503694,0.0139371894077324,-0.0408102832895249,0.013823499188786,0.332981579674288
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,14877,-0.0156619546638246,0.0144510406443128,-0.0439859943266776,0.0126620849990284,0.27847362213316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,14879,-0.00543265366287609,0.0142556958146745,-0.0333738174596382,0.022508510133886,0.703144488771346
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21040.Satisfaction with bowel habits,14807,-0.0324936424035212,0.0132351692851809,-0.0584345742024757,-0.00655271060456661,0.0140960376198485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,14791,-0.0305395926457075,0.0140879680740962,-0.0581520100709361,-0.00292717522047887,0.0301914740084509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,14800,0.00149481471889345,0.014293232974067,-0.0265199219102778,0.0295095513480647,0.916708926441857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21043.Least number of times bowels opened per week,14694,-0.00837109864994564,0.0141630913080789,-0.0361307576137803,0.0193885603138891,0.55449585333826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21044.Average number of times bowels opened per day,14751,-0.000769567494778653,0.0159070308022362,-0.0319473478671616,0.0304082128776043,0.961414788516565
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,14884,-0.0012577930400391,0.0143534638079247,-0.0293905821035714,0.0268749960234932,0.930171992407242
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,14874,-0.00500178593482426,0.0144489326600748,-0.0333216939485708,0.0233181220789223,0.729219916704564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,8377,-0.0413385062836911,0.0221205674365257,-0.0846948184592814,0.00201780589189924,0.0616881603247677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,14880,0.00601960131384658,0.0156602510273024,-0.0246744906996661,0.0367136933273592,0.700696924516626
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,14877,0.0206643658144754,0.0217212810623141,-0.0219093450676602,0.0632380766966109,0.341446290451678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,14877,0.0146323330374347,0.0169477339224717,-0.0185852254506098,0.0478498915254792,0.387942552509843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,14875,0.0512915482091072,0.0417615558715633,-0.0305611012991569,0.133144197717371,0.219391303502045
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,14884,0.0299882043146063,0.0165175587230552,-0.00238621078258191,0.0623626194117945,0.0694618819500422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,14880,0.0162375274690507,0.0164309332755355,-0.015967101750999,0.0484421566891003,0.323056512655387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,14525,-0.00491153628206974,0.0149355906911082,-0.0341852940366418,0.0243622214725023,0.742275470371929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,14876,0.0138025480980977,0.014692307530976,-0.0149943746626153,0.0425994708588108,0.347519918241984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,14880,0.0373506384900506,0.0214255210073295,-0.00464338268431511,0.0793446596644164,0.0813057487445668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,14884,0.0129999807501236,0.0143896013801989,-0.0152036379550661,0.0412035994553134,0.366312979973113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,14883,-0.0120167618601555,0.0144073719356939,-0.0402552108541156,0.0162216871338045,0.404254737785358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X21100.Water hardness (USGS classification),43525,0.0118346080472629,0.00836264435922303,-0.00455617489681423,0.0282253909913401,0.157024250978574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,37965,-0.00284239606405729,0.00591946785251975,-0.014444553054996,0.00875976092688143,0.631103857108491
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2149.Lifetime number of sexual partners,35200,-0.00240434023345049,0.00942443672140397,-0.0208762362074023,0.0160675557405013,0.798633716574578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22032.IPAQ activity group,35165,-0.00548119640700459,0.00920091291429161,-0.0235149857190162,0.012552592905007,0.551364056235796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22033.Summed days activity,36094,-0.00157480123649403,0.00578075987754613,-0.0129050905964844,0.00975548812349639,0.785299773328534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22034.Summed minutes activity,35165,0.00260017075011643,0.005827379368119,-0.00882149281139681,0.0140218343116297,0.655456265640051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22037.MET minutes per week for walking,33662,-0.00591696742958712,0.00595087947857075,-0.0175806912075858,0.00574675634841155,0.320083334447324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22038.MET minutes per week for moderate activity,35165,0.00876855216269548,0.00583580264078162,-0.00266962101323649,0.0202067253386274,0.132965571764627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,35165,-0.00227395271583869,0.00914145680894275,-0.0201912080613665,0.0156433026296891,0.803554325377642
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,33662,0.00205590066698428,0.00596862174940789,-0.00964259796185518,0.0137543992958237,0.730508922885492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,37347,-0.00644038905976295,0.00573747730997219,-0.0176858445873085,0.00480506646778255,0.261651884331891
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X22501.Year ended full time education,10401,0.0126167625735869,0.0266931635039551,-0.0397018378941652,0.064935363041339,0.636466450326576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X22506.Tobacco smoking,10336,0.0836845316556753,0.0344060564524876,0.0162486610087996,0.151120402302551,0.0150217495245011
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,41100,-0.00906183406858978,0.0219214408022607,-0.0520278580410208,0.0339041899038412,0.679332091533176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23098.Weight,43043,-0.0128223759466125,0.0130330382586221,-0.038367130933512,0.0127223790402869,0.325201547043796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23099.Body fat percentage,43013,0.0479011652498207,0.0125221848427868,0.0233576829579585,0.0724446475416829,0.000130795181997417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23100.Whole body fat mass,42969,0.0288364998143465,0.01209791883919,0.005124578889534,0.052548420739159,0.0171489269039
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23101.Whole body fat-free mass,43039,-0.0322776557564407,0.010893805167446,-0.0536295138846348,-0.0109257976282466,0.00304885856996735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23102.Whole body water mass,43043,-0.0334676692557658,0.0109091670561939,-0.0548496366859058,-0.0120857018256258,0.00215739976122438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23104.Body mass index (BMI),43043,0.114148130061679,0.022941392848991,0.0691830000776566,0.159113260045702,6.52825378687876e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23105.Basal metabolic rate,43041,-0.0330708270199025,0.011651717019875,-0.0559081923788576,-0.0102334616609474,0.00453787029347882
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23106.Impedance of whole body,43037,0.0261368089239566,0.00891126345416842,0.00867073255378649,0.0436028852941267,0.00335871987100434
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23107.Impedance of leg (right),43040,0.0550798179170873,0.00729142988050444,0.0407886153512986,0.069371020482876,4.30266363253841e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23108.Impedance of leg (left),43039,0.0552491028474499,0.00722997270829347,0.0410783563391947,0.0694198493557051,2.18847678503277e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23109.Impedance of arm (right),43032,-0.0131466322321546,0.00889195699615185,-0.0305748679446122,0.00428160348030299,0.139285114458921
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23110.Impedance of arm (left),43038,-0.0111490636226834,0.00889464516606345,-0.0285825681481677,0.00628444090280101,0.210045907449526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23111.Leg fat percentage (right),43039,0.0992540895053768,0.0151472111942256,0.0695655555646947,0.128942623446059,5.71686509913286e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23112.Leg fat mass (right),43038,0.0751015787712736,0.016084306084543,0.0435763388455694,0.106626818696978,3.0321883740147e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23113.Leg fat-free mass (right),43037,-0.0667466770838502,0.0114037775054641,-0.0890980809945599,-0.0443952731731405,4.86183035354933e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23114.Leg predicted mass (right),43036,-0.0676795009207403,0.0114631601113252,-0.0901472947389376,-0.045211707102543,3.5725810324618e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23115.Leg fat percentage (left),43033,0.109908213174449,0.0157679421294201,0.0790030466007857,0.140813379748113,3.20676546444951e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23116.Leg fat mass (left),43033,0.0797074858598904,0.0167707902339327,0.0468367370013823,0.112578234718398,2.01309406930674e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23117.Leg fat-free mass (left),43030,-0.0637048357286403,0.0118953071785025,-0.0870196377985052,-0.0403900336587753,8.57762395138593e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23118.Leg predicted mass (left),43029,-0.0653472131682645,0.0119572338493789,-0.0887833915130472,-0.0419110348234819,4.65267151343981e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23119.Arm fat percentage (right),43029,0.0200462247911318,0.0138824359382185,-0.0071633496477765,0.04725579923004,0.148746515873592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23120.Arm fat mass (right),43026,0.0203545946339267,0.0137491086102731,-0.0065936582422086,0.0473028475100619,0.138765818918708
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23121.Arm fat-free mass (right),43026,-0.00204944875366193,0.0109787588732892,-0.0235678161453087,0.0194689186379848,0.851917128863077
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23122.Arm predicted mass (right),43025,-0.000625687968991835,0.0109908382873495,-0.0221677310121968,0.0209163550742131,0.954602703469594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23123.Arm fat percentage (left),43021,0.0186522843084908,0.0142356341970678,-0.00924955871776203,0.0465541273347436,0.19011721419024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23124.Arm fat mass (left),43021,0.023162360970275,0.0137083439223606,-0.00370599311755173,0.0500307150581017,0.0911013769420061
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23125.Arm fat-free mass (left),43017,0.00119042661505966,0.0111873446588006,-0.0207367689161895,0.0231176221463088,0.915258883915481
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23126.Arm predicted mass (left),43014,0.00164423157114598,0.011228379651585,-0.0203633925459607,0.0236518556882526,0.883578418623454
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23127.Trunk fat percentage,43012,0.0197184191128949,0.00896042266817864,0.00215599068326473,0.037280847542525,0.0277687570335166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23128.Trunk fat mass,43008,0.0109793061628736,0.0098727198507837,-0.00837122474466245,0.0303298370704097,0.266107714534194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23129.Trunk fat-free mass,43003,-0.0185346112221991,0.00987784717951459,-0.0378951916940477,0.000825969249649474,0.0606096610701956
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23130.Trunk predicted mass,42998,-0.0186636293596188,0.00989072513337499,-0.0380494506210338,0.000722191901796204,0.0591693559687799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23400.Total Cholesterol,24445,0.121636033146297,0.00721527809848153,0.107494088073273,0.135777978219321,2.08866911467824e-63
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,24445,0.135213199216841,0.00696578948040731,0.121560251835243,0.148866146598439,2.64255099233632e-83
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",24445,0.139491860880305,0.00697249750600129,0.125825765768542,0.153157955992067,2.49080929889236e-88
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23403.VLDL Cholesterol,24445,0.159435054453961,0.00695498480229757,0.145803284241458,0.173066824666464,4.40389495435466e-115
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,24445,0.111961973026958,0.00698938603886391,0.0982627763907852,0.125661169663132,1.85219602769461e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23405.LDL Cholesterol,24445,0.126294760385625,0.00695829143607274,0.112656509170922,0.139933011600327,3.86780127169885e-73
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23406.HDL Cholesterol,24445,-0.0164036108951935,0.00818347024366025,-0.0324432125727676,-0.000364009217619431,0.0450295717095973
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23407.Total Triglycerides,24445,0.188080026936464,0.0073433561692358,0.173687048844761,0.202473005028166,8.53757785630447e-143
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,24445,0.185305281161955,0.00739952860706563,0.170802205092106,0.199808357231804,1.10653980181392e-136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23409.Triglycerides in LDL,24445,0.170877814043663,0.00714451272039311,0.156874569111693,0.184881058975634,5.52827411759528e-125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23410.Triglycerides in HDL,24445,0.161632464671223,0.00710131985172603,0.14771387776184,0.175551051580606,1.69653342319515e-113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,24445,0.144364853481173,0.00731061276923582,0.130036052453471,0.158693654508875,3.9775936691136e-86
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,24445,0.17784408794231,0.00709965493333422,0.163928764272974,0.191759411611645,9.36284235492729e-137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23413.Phospholipids in LDL,24445,0.124755290313083,0.00694372789944506,0.11114558363017,0.138364996995995,1.03049234399593e-71
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23414.Phospholipids in HDL,24445,0.0362758934621218,0.00786728473499056,0.0208560153815403,0.0516957715427033,4.02804115290601e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,24445,0.116411151569998,0.00725782786096975,0.102185808962497,0.130636494177499,1.33557782337133e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,24445,0.14759221189777,0.00692693236983443,0.134015424452894,0.161168999342645,7.92209900783402e-100
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,24445,0.136223820961734,0.00693531871061641,0.122630596288926,0.149817045634543,3.07690280447706e-85
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,24445,-0.0274279705308297,0.00815214656251387,-0.0434061777933569,-0.0114497632683026,0.00076797900349619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23419.Total Free Cholesterol,24445,0.13220580674672,0.00711492400942383,0.118260555688249,0.146151057805191,1.53033501725014e-76
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,24445,0.172275509671184,0.00703604838098917,0.158484854844445,0.186066164497923,8.114950993653e-131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,24445,0.0955359221969674,0.00704892315214418,0.0817200328187648,0.10935181157517,1.07250975410947e-41
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,24445,0.0212204962744555,0.00817558598126587,0.00519634775117441,0.0372446447977366,0.00944842356145161
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,24445,0.162542279932884,0.00702809707886262,0.148767209658314,0.176317350207455,4.4355716302544e-117
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,24445,0.185124250156068,0.00718430655765869,0.171043009303057,0.199205491009079,1.73164146961955e-144
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23425.Total Lipids in LDL,24445,0.132250963930209,0.00694450528965317,0.118639733562489,0.145862194297929,2.81574592680052e-80
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23426.Total Lipids in HDL,24445,0.0263190064712094,0.00798883954432526,0.0106608809643319,0.041977131978087,0.000987471056383162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,24445,0.0907681045089444,0.00748284010638748,0.076101737900425,0.105434471117464,9.14212760013345e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,24445,0.170048775009353,0.0070038654493061,0.156321198728713,0.183776351289993,1.08736303455329e-128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,24445,0.128873831122091,0.00691958678331928,0.115311441026785,0.142436221217397,6.93573530649847e-77
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,24445,0.0715733573872456,0.00751344624378014,0.0568470027494365,0.0862997120250547,1.7806141127217e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,24445,0.167502481119832,0.00770869307647442,0.152393442689942,0.182611519549722,1.04702908256393e-103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,24445,-0.0499948701435151,0.00728332163552391,-0.064270180549142,-0.0357195597378882,6.84190349606344e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,24445,-0.0926074147453433,0.00830985538368848,-0.108894731297373,-0.0763200981933139,8.95860669650841e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23434.Phosphoglycerides,24422,0.140870737818342,0.00736349359295353,0.126438290376153,0.155303185260531,5.46597125629722e-81
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,24422,0.155329000287466,0.00784815065790968,0.139946624997963,0.170711375576969,1.67209714966998e-86
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23436.Total Cholines,24422,0.135727086467765,0.00743788320892294,0.121148835378276,0.150305337557254,6.6494231443391e-74
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23437.Phosphatidylcholines,24422,0.128277548060489,0.00746954430013112,0.113637241232232,0.142917854888746,1.02255050934902e-65
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23438.Sphingomyelins,24421,0.105860074815546,0.00750899032531482,0.0911424537779289,0.120577695853163,5.88466619127722e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23439.Apolipoprotein B,24445,0.132620380784204,0.0069278629582179,0.119041769386097,0.146198992182311,4.34453999403105e-81
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23440.Apolipoprotein A1,24445,0.0485031776824623,0.00777075527285087,0.0332724973476746,0.06373385801725,4.39790754633441e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,24445,0.0941353990452133,0.00708265809516325,0.0802533891786933,0.108017408911733,3.60160163537422e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23442.Total Fatty Acids,24422,0.183027469702103,0.00702475061061817,0.169258958505291,0.196795980898914,1.24361586949299e-147
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23443.Degree of Unsaturation,24422,-0.0951210324263535,0.00762757967055809,-0.110071088580647,-0.0801709762720596,1.38542752949763e-35
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,24422,0.0648706949578727,0.00722467885856384,0.0507103243950876,0.0790310655206579,2.92374389719391e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,24422,0.152724078679911,0.00706310122411857,0.138880400280639,0.166567757079183,1.00945198480952e-102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,24422,0.147078262403661,0.00710760868462364,0.133147349381798,0.161009175425523,2.5818808581524e-94
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,24422,0.193860633669959,0.00718181903754344,0.179784268356374,0.207936998983544,3.72343112188296e-158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,24422,0.183991345316609,0.00705939776806561,0.1701549256912,0.197827764942017,9.9806339416841e-148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23449.Linoleic Acid,24422,0.150524857826558,0.00703368096775652,0.136738843129756,0.164310872523361,1.11166289813705e-100
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,24422,0.0133836143519959,0.00744002584367789,-0.00119883630161275,0.0279660650056046,0.0720521262629841
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,24422,-0.0296142293316997,0.00727182122159243,-0.0438669989260209,-0.0153614597373785,4.66651241428098e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,24422,-0.145468070764833,0.00755063527885911,-0.160267315911397,-0.130668825618269,4.24845276811219e-82
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,24422,-0.16222328766335,0.00766767154849897,-0.177251923898408,-0.147194651428292,1.8313062370452e-98
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,24422,0.157703320066581,0.00782569332817664,0.142364961143355,0.173041678989807,1.38547463157993e-89
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,24422,0.0865412585281778,0.00711123686415483,0.0726032342744343,0.100479282781921,5.65817025567341e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,24422,-0.0444150072192275,0.00757999509358975,-0.0592717976026634,-0.0295582168357916,4.70213834976232e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,24422,-0.101893984978807,0.00742345532635689,-0.116443957418467,-0.0873440125391479,1.02318872581593e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,24422,-0.168744727377144,0.00780949285474839,-0.184051333372451,-0.153438121381837,1.39338934211222e-102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,24420,-0.00786392406400211,0.00720572194414866,-0.0219871390745335,0.00625929094652927,0.275132155158633
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23460.Alanine,24436,0.0773785772492852,0.00709653163391793,0.0634693752468061,0.0912877792517643,1.28117653802372e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23461.Glutamine,24366,-0.0852040993747775,0.00703038438702372,-0.098983652773344,-0.0714245459762111,1.04244768299563e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23462.Glycine,24415,0.0549151677653508,0.00741872539503855,0.0403744659910752,0.0694558695396264,1.38239046580762e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23463.Histidine,24412,0.0551184694975517,0.00699246604895877,0.0414132360415925,0.0688237029535109,3.34107201829287e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),24426,0.0864569436014744,0.00740819667030251,0.0719368781276815,0.100977009075267,2.18689703682539e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23465.Isoleucine,24440,0.0633647288788779,0.00723071285552013,0.0491925316820584,0.0775369260756974,2.01746879039682e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23466.Leucine,24441,0.0778811955896211,0.00738031399715656,0.0634157801551942,0.0923466110240479,5.62269736016736e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23467.Valine,24426,0.0907837051355945,0.00742663893022639,0.0762274928323508,0.105339917438838,2.91254100613101e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23468.Phenylalanine,24434,0.0273030168911355,0.00706648606954367,0.0134527041948299,0.0411533295874411,0.000111955607888607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23469.Tyrosine,24414,0.0497126177819362,0.00720508191893475,0.0355906572208241,0.0638345783430483,5.3401522284383e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23470.Glucose,24400,0.0145855228588637,0.00714789471192971,0.00057564922348142,0.0285953964942459,0.0413079063795261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23471.Lactate,24400,0.141114286254533,0.00703986278067653,0.127316155204407,0.154912417304659,1.15588521508897e-88
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23472.Pyruvate,24365,0.0435216512317743,0.00702425047833001,0.0297541202942474,0.0572891821693011,5.88761451151881e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23473.Citrate,24441,0.0586366967313081,0.00711659995226819,0.0446881608248625,0.0725852326377538,1.81631248195377e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,24056,0.0258233894853696,0.00721223487167909,0.0116874091368786,0.0399593698338606,0.000343616323080523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23475.Acetate,24423,-0.0989880760137307,0.00698465633834606,-0.112678002436889,-0.0852981495905724,2.06156155783309e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23476.Acetoacetate,24443,0.02798099479018,0.00705261647529866,0.0141578664985946,0.0418041230817654,7.28491087105254e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23477.Acetone,24443,-0.0682582362961336,0.007033608432581,-0.0820441088239924,-0.0544723637682748,3.16173001634477e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23478.Creatinine,23845,0.0671409149470564,0.00854025133054953,0.0504020223391793,0.0838798075549334,3.94921858389668e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23479.Albumin,24441,0.0880561720448119,0.00709834518030095,0.074143415491422,0.101968928598202,3.12850787187396e-35
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,24445,0.204273760306096,0.00739413211775272,0.189781261355301,0.218766259256891,1.86747504594363e-165
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,24445,0.164318068872901,0.00745966608638814,0.14969712334358,0.178939014402222,1.7078449600826e-106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,24445,0.15860217023679,0.00744180304317895,0.144016236272159,0.17318810420142,7.08567185542029e-100
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,24445,0.16456206540698,0.0074923611389368,0.149877037574664,0.179247093239296,6.74566231491622e-106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,24445,0.171825185636415,0.00741058376282713,0.157300441461274,0.186349929811557,1.16312015112224e-117
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,24445,0.174386675287135,0.00736552016627713,0.159950255761232,0.188823094813038,1.52694909234943e-122
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,24445,0.16425675094958,0.00742687920209877,0.149700067713466,0.178813434185693,2.47974539521287e-107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,24445,0.146335510829177,0.007417029808267,0.131798132404974,0.160872889253381,5.6077866341645e-86
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,24445,0.185914254097861,0.00745603095235401,0.171300433431247,0.200528074764475,1.54783286153583e-135
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,24445,0.183921831185766,0.00744784097858248,0.169324062867744,0.198519599503788,5.22033422495712e-133
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,24445,0.180545574425157,0.00741034535091452,0.166021297537365,0.19506985131295,1.44957488038586e-129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,24445,0.178436230691831,0.00725315548847787,0.164220045934415,0.192652415449248,4.96029884783059e-132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,24445,0.171845856814565,0.00715657744689583,0.157818965018649,0.185872748610481,5.96259416194535e-126
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,24445,0.17919013273746,0.00735042749786338,0.164783294841647,0.193596970633272,1.03332554490237e-129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,24445,0.180621869652921,0.00752242393592332,0.165877918738511,0.195365820567331,6.12880352002346e-126
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,24445,0.185408635961402,0.00736190713327667,0.170979297980179,0.199837973942624,3.4011628848602e-138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,24445,0.183465089384969,0.00734541736984402,0.169068071340075,0.197862107429864,5.55237331410715e-136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,24445,0.18329611222313,0.00738991988315562,0.168811869252145,0.197780355194115,3.75117699243043e-134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,24445,0.178984325905719,0.00721132532420308,0.164850128270281,0.193118523541157,2.52299091163681e-134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,24445,0.168669433598606,0.00708814627931038,0.154776666891158,0.182562200306054,9.40899883169311e-124
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,24445,0.185880150268498,0.00735100613441575,0.171472178245043,0.200288122291953,2.79182584937941e-139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,24445,0.178961664452541,0.00737527111019073,0.164506133076567,0.193417195828515,1.52251739650683e-128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,24445,0.160736205987396,0.00694597326978344,0.147122098378621,0.174350313596172,3.27130907916155e-117
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,24445,0.172060607385721,0.00699238227873031,0.15835553811941,0.185765676652032,4.32712325895073e-132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,24445,0.157841750582665,0.00693450120164769,0.144250128227436,0.171433372937895,1.66283902876628e-113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,24445,0.115213415571843,0.00695498142046821,0.101581651987726,0.128845179155961,2.66956657816467e-61
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,24445,0.086943768927447,0.00704426675228817,0.0731370060929622,0.100750531761932,6.79560539910957e-35
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,24445,0.144796674915761,0.00691947048228604,0.13123451277048,0.158358837061041,2.17886500105423e-96
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,24445,0.185488593124133,0.00723896055526345,0.171300230435816,0.199676955812449,6.42473569127873e-143
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,24445,0.172369467657386,0.00708222894272306,0.158488298929649,0.186250636385124,2.67206314034712e-129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,24445,0.174806717922351,0.00705418075003661,0.160980523652279,0.188632912192422,6.53996125081581e-134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,24445,0.158939162584045,0.00695019091851486,0.145316788383756,0.172561536784334,1.53288764467812e-114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,24445,0.145288898928544,0.00694168955350994,0.131683187403665,0.158894610453424,2.0094468820748e-96
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,24445,0.146896927974367,0.00696872783874947,0.133238221410418,0.160555634538316,9.12207851251712e-98
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,24445,0.139514936201365,0.00691935795515447,0.125952994609263,0.153076877793468,1.11174775441162e-89
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,24445,0.176206126749243,0.0072765458726565,0.161944096838836,0.19046815665965,4.92007474450046e-128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,24445,0.134458879122739,0.00702676663776993,0.12068641651271,0.148231341732768,5.03506784587615e-81
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,24445,0.135280134532033,0.00704847032300998,0.121465132698934,0.149095136365133,1.69230832677391e-81
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,24445,0.130154893602498,0.00703805842093141,0.116360299097472,0.143949488107523,7.74739044423293e-76
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,24445,0.107564122143022,0.00716293767731126,0.0935247642954922,0.121603479990552,9.60905241879123e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,24445,0.0995095641277195,0.0072261792534102,0.0853462527910355,0.113672875464403,5.53691947798276e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,24445,0.122822953182689,0.00705554442091605,0.108994086117693,0.136651820247684,1.8331810312501e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,24445,0.158716459994866,0.00718339503302638,0.144637005730135,0.172795914259598,3.96517970345362e-107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,24445,0.105313061055074,0.00703935065971986,0.0915159337620228,0.119110188348125,2.22017700680573e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23524.Total Lipids in IDL,24445,0.108970912089448,0.00722845581251082,0.0948031386969271,0.12313868548197,4.00147085904003e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23525.Phospholipids in IDL,24445,0.105926974987034,0.00723392288809918,0.0917484861263598,0.120105463847709,2.39116738080279e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23526.Cholesterol in IDL,24445,0.0959846434664533,0.00726784756456112,0.0817396622399135,0.110229624692993,1.09735549355211e-39
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,24445,0.0986786558225748,0.00726738498431245,0.0844345812533224,0.112922730391827,7.64335517356598e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,24445,0.0857627011944778,0.00725540772390197,0.0715421020556299,0.0999833003333256,3.74177538910083e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23529.Triglycerides in IDL,24445,0.153499073111543,0.0071282283395247,0.139527745566075,0.167470400657012,6.63549034206248e-102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,24445,0.116136939354367,0.00694586196217308,0.102523049908508,0.129750828800226,2.07386309024224e-62
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,24445,0.123868274249546,0.00700808175997127,0.110132434000002,0.13760411449909,1.76823509004695e-69
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,24445,0.118782714911225,0.00700092135631276,0.105060909052852,0.132504520769598,3.37803484866703e-64
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,24445,0.117034996792161,0.0070303293362553,0.103255551293101,0.130814442291222,6.96133356573784e-62
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,24445,0.12454291222372,0.00699971682314481,0.110823467250356,0.138262357197083,2.24514653482875e-70
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,24445,0.0935145528445089,0.00712699246819101,0.0795456476068545,0.107483458082163,3.37969002171289e-39
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,24445,0.162545411126859,0.00712367910406174,0.148583000082898,0.17650782217082,4.77370847153093e-114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,24445,0.14313230269177,0.00690777910517802,0.129593055645621,0.156671549737919,1.47452565916042e-94
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,24445,0.146698250972786,0.00690621011755704,0.133162079142374,0.160234422803198,3.12185155873332e-99
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,24445,0.139564018720423,0.00690472553705982,0.126030756667786,0.15309728077306,4.12263002130952e-90
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,24445,0.142141954030259,0.00690469838997337,0.128608745185911,0.155675162874606,2.26130721381991e-93
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,24445,0.153443989180645,0.00691331773881118,0.139893886412575,0.166994091948715,4.4534520683241e-108
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,24445,0.104273505902434,0.00694811073926979,0.090655208853465,0.117891802951403,1.10412454044694e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,24445,0.176965885246013,0.0071765399706129,0.162899866903612,0.191031903588414,1.23506282769146e-132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,24445,0.138311392094243,0.00690776200647863,0.124772178561545,0.151850605626941,1.79504097023705e-88
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,24445,0.132636977057393,0.00691397763418628,0.119085580894388,0.146188373220398,2.00508246780767e-81
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,24445,0.103363913552321,0.00693657719429141,0.0897682222515103,0.116959604853133,5.36249973881506e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,24445,0.131384906846017,0.00690716143965656,0.11784687042429,0.144922943267743,4.29273848204119e-80
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,24445,0.147756261595401,0.00690934409508027,0.134213947169044,0.161298576021759,1.54027836564126e-100
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,24445,0.0784187429152477,0.00695991784966208,0.06477730392991,0.0920601819005854,2.2516293638338e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,24445,0.184072807506211,0.00724318588330847,0.169876163174926,0.198269451837495,1.20972384054542e-140
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,24445,-0.0457103132404816,0.00819346704404138,-0.0617695086468027,-0.0296511178341605,2.44644919324438e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,24445,-0.078340879692114,0.00821182270866853,-0.0944360522011043,-0.0622457071831237,1.55705266083283e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,24445,-0.086170951479916,0.0081776468365022,-0.10219913927946,-0.0701427636803717,6.60322123644671e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,24445,-0.0855340165128293,0.00823828211578961,-0.101681049459777,-0.0693869835658816,3.36078236265625e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,24445,-0.0870667894428848,0.008334499028059,-0.10340240753788,-0.0707311713478891,1.71959322639665e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,24445,-0.0750913582294006,0.00780539203068917,-0.0903899266095514,-0.0597927898492498,7.16695702987932e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,24445,0.131995164151249,0.00703426731586599,0.118208000212151,0.145782328090346,5.20620421460763e-78
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,24445,-0.0664902220743201,0.00849171143032166,-0.0831339764777506,-0.0498464676708897,5.07541481311928e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,24445,-0.0675497801461455,0.00842674071663453,-0.0840661919507492,-0.0510333683415419,1.1398654699539e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,24445,-0.0574220011641151,0.00832677169431758,-0.0737424736849775,-0.0411015286432526,5.47635616971589e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,24445,-0.092052359116477,0.00848420495327708,-0.1086814008249,-0.0754233174080539,2.30630407729632e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,24445,-0.0990511630525355,0.00848135649217535,-0.115674621777199,-0.0824277043278718,1.98548999325076e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,24445,-0.0666671173323755,0.00843744066690023,-0.0832045010394999,-0.050129733625251,2.87484585987586e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,24445,0.107127166080766,0.0072052517998773,0.0930048725530061,0.121249459608525,8.79050814980553e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,24445,0.0393039357488138,0.00769441322418396,0.0242228858294132,0.0543849856682144,3.27836891340163e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,24445,0.0487640148201038,0.00759286286853368,0.0338820035977778,0.0636460260424298,1.36655278909362e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,24445,0.0611053615621443,0.00749781883074122,0.0464096366538915,0.0758010864703971,3.81994978640412e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,24445,0.0105893989710899,0.00775656202638506,-0.00461346260062478,0.0257922605428047,0.172197077826568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,24445,0.00307010173029402,0.00772792093027676,-0.0120766232930484,0.0182168267536365,0.691168920126074
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,24445,0.0404172232924471,0.00782605017897364,0.0250781649416588,0.0557562816432354,2.43041669369755e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,24445,0.159374262027579,0.00710704853384637,0.14544444690124,0.173304077153918,2.92450594355445e-110
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,24445,0.120919277509281,0.00694610795960372,0.107304905908457,0.134533649110104,1.82684170051604e-67
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,24445,0.139525262712435,0.00698650545859252,0.125831712013593,0.153218813411276,4.99874297646862e-88
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,24445,0.136684024193148,0.0070240734871154,0.122916840158402,0.150451208227894,1.04530755758769e-83
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,24445,0.105648800862282,0.00695836751961035,0.0920104005238455,0.119287201200718,7.90661379140392e-52
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,24445,0.0886441540383445,0.00693798844961262,0.0750456966771038,0.102242611399585,2.91475895065989e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,24445,0.141346897306632,0.00706903395732657,0.127491590750272,0.155202203862992,3.08163478327945e-88
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,24445,0.183942495939885,0.00742801726093007,0.169383582108462,0.198501409771308,9.92816069495687e-134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,0.0293380618394246,0.00713622295251623,0.0153510648524928,0.0433250588263564,3.95042136669403e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,-0.0166789727197423,0.00722146031087509,-0.0308330349290574,-0.00252491051042708,0.0209167689752843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,0.00690460415513951,0.00714746731360795,-0.00710443177953206,0.0209136400898111,0.334043621061088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,-0.0544932011914374,0.00728800068854359,-0.0687776825409828,-0.0402087198418919,7.86445112092853e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,0.00120768301812241,0.00711842730668272,-0.0127444345029757,0.0151598005392205,0.865282244912019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,24185,0.0502300207802547,0.00696108984035345,0.036586284693162,0.0638737568673475,5.51882257235667e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,24185,-0.0911939555608769,0.00761319484375938,-0.106115817454645,-0.0762720936671085,5.71715001096299e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,24185,-0.0921283131670169,0.00760416777183315,-0.10703248199981,-0.0772241443342239,1.09483031411069e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,24185,-0.0637638395436201,0.00738040971534405,-0.0782294425856944,-0.0492982365015458,5.98372539745877e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,24185,0.0617454883022884,0.00743897903909869,0.047165089385655,0.0763258872189218,1.09251667629055e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,24440,0.116392417205233,0.00738104586040539,0.101925567318838,0.130859267091627,9.5679164200802e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,24440,-0.0217820159798907,0.00716733010047386,-0.0358299829768195,-0.00773404898296194,0.00237560793781092
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,24440,-0.0489408094063884,0.00742473423067152,-0.0634932884985046,-0.0343883303142722,4.44008564999863e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,24440,0.0409578109152405,0.00700983823882558,0.0272185279671423,0.0546970938633386,5.1949489554415e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,24440,-0.0322100813488639,0.00694113085269006,-0.0458146978201364,-0.0186054648775914,3.49428593259111e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,24445,-0.00840518616763749,0.00734099561406183,-0.0227935375711987,0.0059831652359237,0.252234696097
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,24445,-0.07373412,0.007652992,-0.08873399,-0.05873426,6.24345e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,24445,-0.0847536660269524,0.0077035338641372,-0.0998525924006613,-0.0696547396532435,4.3544174986835e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,24445,-0.0415011532717704,0.00747976147389612,-0.0561614857606068,-0.026840820782934,2.9118483733685e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,24445,0.059452590834158,0.00759343436449786,0.0445694594797422,0.0743357221885738,5.09725075602516e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,24445,-0.0479790167926766,0.00746974693189163,-0.0626197207791842,-0.033338312806169,1.35973401081502e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,24445,-0.0360226032354768,0.00724103539411389,-0.05021503260794,-0.0218301738630136,6.57628571803337e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,24445,-0.0233220691626267,0.00706621007511794,-0.0371718409098579,-0.00947229741539555,0.000966488434363995
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,24445,-0.0511352834847201,0.00751222274177127,-0.0658592400585918,-0.0364113269108485,1.02000604892345e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,24445,0.0401661858155393,0.00731338594935375,0.0258319493548059,0.0545004222762726,4.01033412231748e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,24445,-0.0218220846028688,0.00730672789281095,-0.0361432712727782,-0.00750089793295931,0.00282402217677676
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,24445,-0.0531503080824433,0.00762462815651854,-0.0680945792692196,-0.0382060368956669,3.22993246954558e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,24445,-0.0535800972829472,0.00770188598638882,-0.0686757938162693,-0.0384844007496251,3.56996723262362e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,24445,-0.0360277887533386,0.00706289679147538,-0.0498710664646304,-0.0221845110420469,3.40401425820787e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,24445,0.0650271119747353,0.00756443052165554,0.0502008281522904,0.0798533957971802,8.7079854548661e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,24445,-0.0471913118081553,0.00697362232968127,-0.0608596115743306,-0.03352301204198,1.34345302372594e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,24445,-0.0212702116212837,0.00734817652601312,-0.0356726376122695,-0.00686778563029801,0.00379948363208311
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,24445,-0.000125432547185216,0.007309043280281,-0.014451157376536,0.0142002922821655,0.986308090883353
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,24445,-0.058059847252326,0.00711165793335705,-0.0719986968017058,-0.0441209977029462,3.39506258253067e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,24445,0.0463557394979549,0.00748801841896216,0.0316792233967891,0.0610322555991207,6.08681814310774e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,24445,-0.060455490054414,0.00700817056355093,-0.0741915043589738,-0.0467194757498541,6.70809091075099e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,24445,-0.00514863258243002,0.00746311601586258,-0.0197763399735207,0.00947907480866064,0.490278051913308
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,24445,0.0786999364595705,0.00694194834329459,0.0650937177067131,0.0923061552124279,1.02252509975664e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,24445,-0.102592921268002,0.00766884519094191,-0.117623857842248,-0.0875619846937556,1.132480013878e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,24445,0.0311065914453421,0.00736834595359024,0.0166646333763052,0.0455485495143789,2.43394665841491e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,24445,-0.0999914820588387,0.0070015207559999,-0.113714462740599,-0.0862685013770789,4.38273553279277e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,24445,0.0322222577661384,0.00708620741299607,0.0183332912366662,0.0461112242956107,5.46305509033604e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,24445,0.137817000948707,0.00711028052964324,0.123880851110606,0.151753150786808,4.54018975221917e-83
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,24445,-0.138561282669642,0.00758671633586051,-0.153431246687929,-0.123691318651355,5.01210624085384e-74
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,24445,0.0243915807155216,0.00721500072926893,0.0102501792861545,0.0385329821448887,0.000724209094831307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,24445,-0.166592472417073,0.00698822401031894,-0.180289391477298,-0.152895553356848,3.44875986395234e-124
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,24445,0.072305423530279,0.00700707168988732,0.0585715630180999,0.0860392840424582,6.51074779729505e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,24445,0.161440336673706,0.00698814055419045,0.147743581187493,0.175137092159919,7.89645085338983e-117
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,24445,-0.10917199688303,0.00734313034904542,-0.123564532367159,-0.094779461398901,8.88200613843127e-50
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,24445,0.0942201030061142,0.00737476434301136,0.079765564893812,0.108674641118416,2.93795205241628e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,24432,-0.103211648894436,0.0078379863585118,-0.11857410215712,-0.0878491956317533,1.82502630344949e-39
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,24432,0.00630517896914845,0.00734039031812355,-0.0080819860543737,0.0206923439926706,0.390365206642416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,24432,-0.0180601823518933,0.0070648104824703,-0.0319072108975351,-0.00421315380625153,0.0105834299574011
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,24432,0.056194881757463,0.00830325152294591,0.039920508772489,0.072469254742437,1.33699615319209e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,24432,0.176272426036011,0.00771248420747647,0.161155956989357,0.191388895082665,2.04778701667348e-114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,24445,0.0885617317671065,0.00772713322954995,0.0734165506371887,0.103706912897024,2.47219174975935e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,24445,-0.142359548087683,0.00790887459460175,-0.157860942293102,-0.126858153882263,5.69006454728388e-72
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,24445,-0.147043047437045,0.00777861411145961,-0.162289131095505,-0.131796963778584,3.92134005520509e-79
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,24445,-0.0304164709271194,0.00766366850300783,-0.0454372611930147,-0.015395680661224,7.24060824228495e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,24445,0.151361844427694,0.00761870999136806,0.136429172844613,0.166294516010775,3.8246749165525e-87
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,24445,0.0863473125206115,0.00782060391798032,0.07101892884137,0.101675696199853,2.82667185920859e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,24445,-0.128279511252994,0.00766988811987344,-0.143312491967946,-0.113246530538042,1.91585876300605e-62
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,24445,-0.141359196889774,0.00743821434906777,-0.155938097013947,-0.126780296765601,5.91860108995637e-80
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,24445,0.00634712284733029,0.0082289502776987,-0.00978161969695916,0.0224758653916197,0.440526978468574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,24445,0.144492104410373,0.00747635031696551,0.129838457789121,0.159145751031625,1.32973974806323e-82
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,24445,-0.00956629464342223,0.0071440922881931,-0.0235687155282807,0.00443612624143624,0.180566951593131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,24445,-0.0776288028260457,0.00714989863276251,-0.0916426041462602,-0.0636150015058311,2.12590145642882e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,24445,-0.080553144656306,0.00709617373503204,-0.0944616451769688,-0.0666446441356432,8.6448507912413e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,24445,0.020373533718195,0.0074996524878702,0.00567421484196945,0.0350728525944206,0.00660032820219594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,24445,0.141078302056073,0.00760509724970997,0.126172311446641,0.155984292665504,2.70309277753957e-76
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,43318,0.00651519433025925,0.00597210380454612,-0.00519012912665115,0.0182205177871696,0.275306282697949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,43318,0.00111156224259244,0.00583626042162837,-0.0103275081837992,0.012550632668984,0.848951177539298
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,40248,0.00484905989608574,0.00560796192080507,-0.00614254546869219,0.0158406652608637,0.387222798110113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,40248,-0.00139776352506395,0.00612083998877165,-0.0133946099030564,0.0105990828529285,0.819366463657417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,40248,-0.00397532605461923,0.00600719988274713,-0.0157494378248036,0.00779878571556514,0.508128679153084
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,40248,-0.00161451972929702,0.00552793560068172,-0.0124492735066332,0.00922023404803915,0.770237987277252
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,43318,-0.053948268702725,0.0182806913780147,-0.0897784238036337,-0.0181181136018162,0.0031680723768138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24010.Inverse distance to the nearest road,43318,-0.00556095592211607,0.00523474349863624,-0.0158210531794431,0.00469914133521095,0.288097817772207
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,43318,0.00884642820177843,0.005216672010542,-0.00137824893888389,0.0190711053424408,0.0899311030293118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,43318,-0.0032231775384672,0.00532610711171559,-0.0136623474774298,0.00721599240049535,0.545072050006202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24013.Total traffic load on major roads,43318,-0.0180225071557364,0.0127233118355473,-0.0429601983534091,0.00691518404193635,0.156637830616145
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,43318,-0.0200314595194769,0.0123661031186266,-0.0442690216319849,0.00420610259303116,0.105267833640007
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,43318,0.0154553473872191,0.00597383574248609,0.00374662933194641,0.0271640654424919,0.00967992292508081
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,43318,0.012123580089457,0.00596717145507115,0.000427924037517582,0.0238192361413965,0.0421888070844543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,43318,0.0139956530364753,0.00590398774641293,0.00242383705350597,0.0255674690194447,0.0177663615328326
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,43221,0.0329887070989463,0.00577949512239018,0.0216608966590616,0.0443165175388311,1.15134268698882e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,43318,-0.010565992390905,0.00524645347103433,-0.0208490411941323,-0.000282943587677713,0.0440230088741549
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,43318,-0.0105091559963286,0.00524684680827739,-0.0207929757405523,-0.00022533625210489,0.0451892002812688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,43318,-0.0105862213765453,0.00524642573851328,-0.0208692158240313,-0.000303226929059281,0.0436185775404056
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,43318,-0.0105833837924261,0.00524663620062216,-0.0208667907456455,-0.000299976839206628,0.0436834039592159
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,43318,-0.0105815202601661,0.0052468259736536,-0.0208652991685271,-0.00029774135180499,0.0437280881051127
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2405.Number of children fathered,19884,0.00217781904626571,0.0139718244691852,-0.0252069569133374,0.0295625950058688,0.876135340456562
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",38382,-0.00870430223844532,0.00620247868981713,-0.0208611604704869,0.00345255599359625,0.160518004022296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",38382,0.000959610603366953,0.00561833902337087,-0.01005233388244,0.0119715550891739,0.864382167895179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",38382,-0.0129577239751762,0.00557597800898112,-0.0238866408727792,-0.0020288070775732,0.0201388513891215
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",38382,-0.009397004196689,0.00582804380080869,-0.020819970046274,0.00202596165289602,0.106888135818909
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",38382,0.00326110365824231,0.00567528742728324,-0.00786245969923284,0.0143846670157175,0.56555526801373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",38382,-0.0121958559827015,0.0056116233439663,-0.0231946377368755,-0.00119707422852759,0.0297623004521113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",43526,-0.0161071731843397,0.00586174353885214,-0.0275961905204899,-0.00461815584818953,0.00600127326918869
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",43526,-0.0165131517763557,0.00551633285761557,-0.0273251641772822,-0.00570113937542919,0.00275950838736727
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,43526,0.0474055093090727,0.00522652842067853,0.0371615136045428,0.0576495050136027,1.23651658798991e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,9639,-0.0134832034065278,0.0186249440577895,-0.0499880937597953,0.0230216869467396,0.469124734515743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2704.Years since last cervical smear test,18024,0.014556737461677,0.0132675751955945,-0.0114477099216882,0.0405611848450421,0.272583335623617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2714.Age when periods started (menarche),22973,0.0146959880025616,0.0113614664806796,-0.00757248629957044,0.0369644623046937,0.19585329326592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2734.Number of live births,23702,0.00988550106038646,0.0108901763533719,-0.0114592445922225,0.0312302467129955,0.364022300568669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2744.Birth weight of first child,18859,0.0066636242784754,0.0121325612748495,-0.0171161958202296,0.0304434443771804,0.58285086896234
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2754.Age at first live birth,16076,-0.00850662547662279,0.00912866841333883,-0.0263988155667669,0.00938556461352131,0.351423763229169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2764.Age at last live birth,16029,0.00350289433737519,0.00879730524299381,-0.0137398239388927,0.0207456126136431,0.690504211053935
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2794.Age started oral contraceptive pill,18137,0.000496762290197376,0.00995773210710155,-0.0190203926397217,0.0200139172201164,0.960212913922485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2804.Age when last used oral contraceptive pill,16454,-0.00649019903352498,0.00866402732452973,-0.0234716925896033,0.0104912945225533,0.453809310149808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,10768,0.0101101647252942,0.0105847850429206,-0.0106360139588301,0.0308563434094185,0.339518191412561
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",16334,0.00633895125898409,0.0161809243955642,-0.0253756605563217,0.0380535630742898,0.69524467265293
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,16326,0.0150309892496299,0.0178488558538924,-0.0199527682239992,0.050014746723259,0.39972966213661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,16356,0.00426864570788568,0.0185130885460215,-0.0320170078423164,0.0405542992580878,0.81764828441762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",16308,0.0311295986327901,0.0179919885708182,-0.00413469896601351,0.0663938962315937,0.0836148752742665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28739.Difficulty with standing for long periods,16374,-0.0161801016524851,0.0157508336459747,-0.0470517355985954,0.0146915322936253,0.304316222784288
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,16414,-0.0152495334670042,0.0175223283329425,-0.0495932969995715,0.0190942300655631,0.384153861326962
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28741.Difficulty learning a new task,16281,0.0154927612994883,0.0198128116872911,-0.0233403496076022,0.0543258722065788,0.434251390978016
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28742.Difficulty with joining in community activities,15672,-0.0202429609542826,0.0199238061379586,-0.0592936209846815,0.0188076990761163,0.309636151379319
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,16309,-0.00169717768367414,0.0169600579750947,-0.0349388913148598,0.0315445359475115,0.92029070058899
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,16413,-0.0421320267506469,0.0241456460676245,-0.0894574930431909,0.00519343954189706,0.0810189290606576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,10240,-0.00258666151257831,0.0182862930458624,-0.0384277958824687,0.0332544728573121,0.887514420166137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2897.Age stopped smoking,10764,0.00950153163721359,0.0110716132034434,-0.0121988302415355,0.0312018935159627,0.390807493026004
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,14613,-0.0318478602405567,0.0192118870711315,-0.0695031588999743,0.00580743841886101,0.0973962076679084
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,14613,0.0188322602210542,0.0208767290257577,-0.0220861286694309,0.0597506491115393,0.367034839155919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,14613,0.133666403057352,0.0700591413778255,-0.00364951404318628,0.27098232015789,0.0564226936196158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,14613,0.026492211250419,0.0738705663186126,-0.118294098734062,0.1712785212349,0.71987698499936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,14613,0.128119510458502,0.080761596744461,-0.030173219160642,0.286412240077645,0.11267218537486
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,14613,0.110084758100875,0.0676949582843595,-0.0225973601364692,0.24276687633822,0.103931159460312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,14613,0.0109465762393408,0.0302803148066221,-0.0484028407816385,0.0702959932603202,0.717724952468375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,14613,0.0196189691004387,0.054210935817272,-0.0866344651014145,0.125872403302292,0.717431564556472
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,14533,0.0156182623021071,0.0187885959936738,-0.0212073858454936,0.0524439104497077,0.4058388148945
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29003.Recent feelings of depression,14522,0.017037805439313,0.0181548431332364,-0.0185456871018303,0.0526212979804562,0.348017709036193
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",14541,0.0232279544023597,0.0146612128115939,-0.00550802270836436,0.0519639315130837,0.113144211696402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,14551,0.00296061841183193,0.0147396271112531,-0.0259290507262241,0.031850287549888,0.840809958942245
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29006.Recent poor appetite or overeating,14562,-0.0136217555664404,0.0205242006581328,-0.0538491888563807,0.0266056777234998,0.506897736461598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29007.Recent feelings of inadequacy,14501,0.00438622368621775,0.0197441956496205,-0.0343123997870384,0.0430848471594739,0.824198251857113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29008.Recent trouble concentrating on things,14559,-0.0164730565661877,0.0196843179937929,-0.0550543198340218,0.0221082067016464,0.402683926316959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,14543,0.00306812330798812,0.0345301143085377,-0.0646109007367458,0.070747147352722,0.929199522428109
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,14469,-0.00207787145182353,0.0378864741467554,-0.0763353607794642,0.0721796178758171,0.956262964598087
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,13751,0.0144350599497782,0.0364632247655022,-0.0570328605906061,0.0859029804901625,0.692199733877322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),13751,-0.0972431932857702,0.0697598452172444,-0.233972489911569,0.0394861033400288,0.163348943767676
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),13751,-0.0231190445204539,0.0365671602384613,-0.094790678587838,0.0485525895469302,0.527243745576974
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),13751,-0.122903396050625,0.108373375940514,-0.335315212894033,0.0895084207927822,0.256783422015653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),13751,-0.0531167678944677,0.0689889334824595,-0.188335077520088,0.0821015417311529,0.441353638956094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),13751,-0.0342677860027001,0.0735882148210938,-0.178500687052044,0.109965115046644,0.641459481417955
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),13751,-0.101764296185943,0.0851957668474051,-0.268747999206857,0.0652194068349706,0.232312459049171
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),13751,0.0362768110323136,0.095265792612581,-0.150444142488345,0.222997764552972,0.703360685252725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),13751,-0.055111498440849,0.0701228274883285,-0.192552240317973,0.0823292434362748,0.431923184801681
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,13751,-0.00419340307552993,0.0358880853726883,-0.074534050405999,0.0661472442549391,0.906983272123469
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,13751,-0.0930460535086531,0.0555979429969845,-0.202018021782743,0.0159259147654365,0.0942414293250246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,13751,-0.0483337821539821,0.0876813589852532,-0.220189245765078,0.123521681457114,0.581475706558815
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,13751,0.0507341718559285,0.111120039722637,-0.167061106000441,0.268529449712298,0.647986748327212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,13751,0.00537662429114657,0.0725206234673658,-0.13676379770489,0.147517046287183,0.940900667446086
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,13751,0.0376556209838023,0.114756506514656,-0.187267131784924,0.262578373752529,0.742814627471266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,13751,0.0484813366252062,0.108387909210251,-0.163958965426886,0.260921638677298,0.654669350378024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,13751,-0.0839237528455987,0.0598238568656551,-0.201178512302283,0.0333310066110853,0.160684895254472
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,13751,0.043455992637279,0.0587134585749681,-0.0716223861696585,0.158534371444216,0.459229626870876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,13751,-0.0634490156907198,0.0843005117618046,-0.228678018743857,0.101779987362417,0.451671481087497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,14324,0.00670026361324352,0.0171443374520133,-0.0269026377927026,0.0403031650191897,0.695939832494453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29059.Recent inability to stop or control worrying,14338,0.0174264178848183,0.0177952628679732,-0.0174522973364091,0.0523051331060457,0.327461719859509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29060.Recent worrying too much about different things,14332,0.0132558950233889,0.0164054171191318,-0.0188987225301093,0.0454105125768872,0.419092849813153
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29061.Recent trouble relaxing,14334,0.0172069495374958,0.0173901360449372,-0.0168777171105811,0.0512916161855726,0.322451884088129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29062.Recent restlessness,14350,0.0398770924763304,0.0246952422171061,-0.00852558226919755,0.0882797672218583,0.10638290615062
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29063.Recent easy annoyance or irritability,14307,-0.00995572966487346,0.0176585461629547,-0.0445664801442648,0.0246550208145178,0.572905213959649
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29064.Recent feelings of foreboding,14304,0.0178863981126868,0.0200722413817529,-0.0214551949955489,0.0572279912209224,0.372889893480307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,13751,-0.0359995811357019,0.0387236241722891,-0.111897884513389,0.0398987222419847,0.352566473549961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,13751,-0.0627521015088666,0.0634049825417809,-0.187025867290757,0.0615216642730239,0.322336739586097
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',13751,-0.0681162457657361,0.0831170400173031,-0.23102564419965,0.0947931526681781,0.4125028534713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,13751,0.0339534642856392,0.0879493851730953,-0.138427330653628,0.206334259224906,0.699460530432653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,13751,-0.0492929158807935,0.0586188911801881,-0.164185942593962,0.0656001108323751,0.400415820641411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,13751,-0.0542071515124892,0.0629203022375781,-0.177530943898142,0.0691166408731638,0.388966287018022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,13751,-0.0617518379166846,0.0628158946996387,-0.184870991527976,0.0613673156946073,0.325594874402388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,13751,-0.0373831922153447,0.0592935397765655,-0.153598530177413,0.0788321457467237,0.52839326427862
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,13751,-0.100488842822821,0.0770639861635052,-0.251534255703291,0.0505565700576493,0.192266913853851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29076.Felt loved as a child,14281,0.0190987769648142,0.0151940436459501,-0.0106815485812481,0.0488791025108765,0.208777456394184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29077.Physically abused by family as a child,14304,-0.0355170172893742,0.0205218642147505,-0.0757398711502851,0.00470583657153672,0.0835283822742457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29078.Felt hated by family member as a child,14278,0.00825634862837577,0.0207680538036413,-0.0324490368267612,0.0489617340835128,0.690967559497493
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29079.Sexually molested as a child,14175,0.0396985204774402,0.0277238582087646,-0.0146402416117385,0.0940372825666189,0.15218700265478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,14256,-0.0114753448723187,0.0221489252421122,-0.0548872383468587,0.0319365486022213,0.604396968871656
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,14280,-0.0290593617446501,0.0291783392110671,-0.0862489065983415,0.0281301831090413,0.319304741495531
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,14202,0.0161984028993725,0.0226276616345356,-0.0281518139043173,0.0605486197030622,0.474085077407475
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,14292,0.00537610487034776,0.0252433211948882,-0.0441008046716332,0.0548530144123287,0.831352329224559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,14245,0.0284484284873584,0.0354893349937145,-0.0411106681003221,0.0980075250750388,0.422794867712803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,14247,0.00834947032582788,0.033811534965768,-0.0579211382070774,0.0746200788587332,0.804957079245238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29086.Experienced a violent or sexual assault,14296,-0.0167684793521439,0.0284874926076659,-0.0726039648631689,0.0390670061588812,0.55612148545234
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,14301,-0.022473209193035,0.0179215370028471,-0.0575994217186153,0.0126530033325454,0.209870600203971
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29088.Experienced a marital separation or divorce,14301,-0.00235539046280929,0.0167656460557439,-0.0352160567320674,0.0305052758064488,0.888275547628148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29089.Experienced the death of a spouse or partner,14320,-0.00677637218966943,0.022641228537084,-0.051153180122354,0.0376004357430151,0.764720473272497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,14295,0.0268516981188676,0.0210839942372272,-0.0144729305860977,0.0681763268238329,0.202840689947379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,14302,-0.0348070039969249,0.013778009059207,-0.0618119017529707,-0.00780210624087911,0.0115387183196882
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,12722,-0.0493058012051236,0.0159971165996239,-0.0806601497403864,-0.0179514526698608,0.00205938704668227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,12756,-0.0560064561288938,0.0161308319920381,-0.0876228868332884,-0.0243900254244991,0.00051828503523349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29104.Ever used cannabis,14292,-0.0199520082233208,0.0199677979336056,-0.0590888921731879,0.0191848757265462,0.317710277044674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29108.Ever thought that life not worth living,14226,0.0181133607710964,0.0174161551075455,-0.0160223032396927,0.0522490247818856,0.298342670697594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29109.Ever contemplated self-harm,14257,0.0265034880379124,0.0236449216457812,-0.0198405583878188,0.0728475344636435,0.262351214625968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29111.Ever self-harmed,14283,0.0605414193701659,0.0382990945625984,-0.0145248059725269,0.135607644712859,0.113956626775029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,14277,-0.00751180864469293,0.0252507514415882,-0.0570032814702059,0.04197966418082,0.766097905017359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,14811,0.0689754140433712,0.0818922040667901,-0.0915333059275374,0.22948413401428,0.399649992264758
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,14811,-0.043316276790615,0.0642573878670194,-0.169260757009973,0.0826282034287431,0.500254593216801
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,14811,0.0179929403657256,0.0680411448891832,-0.115367703617074,0.151353584348525,0.791442990179852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,14811,0.0500569718783737,0.0941689348913231,-0.13451414050862,0.234628084265367,0.595034834587239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,14259,-0.031078919448627,0.0156096743338246,-0.0616738811429233,-0.000483957754330796,0.0464995511745909
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X29153.Pain or discomfort today,14283,0.0148629750669349,0.0146996702100418,-0.0139483785447471,0.0436743286786168,0.311981209177619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29154.Anxiety or depression today,14283,0.0140213234296128,0.0184155369865771,-0.0220731290640784,0.050115775923304,0.446439411857689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29166.Frequency of confiding in someone close,13922,-0.00310962747077813,0.0143948365028207,-0.0313235070163067,0.0251042520747504,0.828972354516157
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,14240,-0.00938601109035574,0.0194759907613182,-0.0475589529825394,0.0287869308018279,0.629865025838365
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,14240,-0.0228803007074435,0.0195820850063062,-0.0612611873198036,0.0155005859049167,0.242652834111447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,14240,0.00960657895025722,0.0244803037398778,-0.0383748163799033,0.0575879742804178,0.69475324202605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,14240,0.0345599883431285,0.0262448321895874,-0.0168798827484627,0.0859998594347197,0.187916750224357
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,14240,-0.0352399195975798,0.0421675101039517,-0.117888239401325,0.0474084002061655,0.403330639561738
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,14240,0.0185413301936788,0.0200855359763268,-0.0208263203199217,0.0579089807072792,0.355961101618101
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,14233,0.00113354937799494,0.0217519159248525,-0.041500205834716,0.0437673045907059,0.958439687570774
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,14233,-0.0209336706661826,0.0318645952056351,-0.0833882772692273,0.0415209359368622,0.511219162191802
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,14233,-0.000915486142511374,0.0491703822497927,-0.097289435352105,0.0954584630670823,0.985145586018895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,14233,0.0817825503196287,0.0440957554204779,-0.00464513030450805,0.168210230943765,0.0636657519446756
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,14233,0.010068927106871,0.0649622678203095,-0.117257117820936,0.137394972034678,0.876826240602328
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,14233,0.011574546795349,0.0309756586624035,-0.0491377441829619,0.0722868377736598,0.708658483208001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,13991,-0.000947442332024239,0.0178614670991739,-0.0359559178464051,0.0340610331823566,0.957697667503086
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,14179,0.0220108908226513,0.0162918431573934,-0.00992112176583978,0.0539429034111424,0.176705005339768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29173.Frequency of feeling left out,14099,0.0338061859591059,0.016928780880487,0.000625775433351301,0.0669865964848605,0.0458481744094959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29174.Frequency of feeling isolated from others,14156,0.0269838110938253,0.0174662273527684,-0.00724999451760087,0.0612176167052514,0.122389555579064
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,14264,-0.0036208809050486,0.0144116012596341,-0.0318676193739314,0.0246258575638342,0.801626272289438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29176.Ability to make it through stressful events,14264,-0.00121630730421579,0.0140677797103791,-0.0287891555365587,0.0263565409281271,0.931101567829261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29177.Quick recovery from stressful events,14264,0.00282644196072596,0.0142962024722845,-0.0251941148849516,0.0308469988064035,0.843278082294975
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29178.Hard to snap back when something bad happens,14264,0.0101446369720335,0.0141377608408106,-0.0175653742759554,0.0378546482200223,0.473042779561459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29179.Comes through difficult times with little trouble,14264,0.00645727358332833,0.014348446446573,-0.0216656814519548,0.0345802286186115,0.652693534204401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,14264,0.00797839670228898,0.0141888671242583,-0.0198317828612572,0.0357885762658352,0.573920642506361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29181.General happiness,14183,0.0169570011757853,0.0147773616717557,-0.0120066277008559,0.0459206300524264,0.251195009881296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29182.Belief that own life is meaningful,14013,-0.0200977167507983,0.0147292733693103,-0.0489670925546465,0.00877165905304992,0.172440236959436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,9803,0.0252933305326225,0.0173788092343619,-0.00876913556672688,0.0593557966319718,0.145587258378271
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2946.Father's age,9516,0.000599625662761462,0.0169861560142135,-0.0326932401250969,0.0338924914506198,0.971840590944347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,10901,0.0157738453645122,0.0128333300278122,-0.00937948148999965,0.0409271722190241,0.219049212207354
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,42517,0.0839117192712943,0.00552325620287232,0.0730861371136646,0.094737301428924,5.43798224280286e-52
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,42518,0.00240589760914821,0.00623582123590204,-0.00981631201321979,0.0146281072315162,0.69963273740522
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30020.Haemoglobin concentration,42518,-0.0563521217147747,0.00668487367614594,-0.0694544741200207,-0.0432497693095286,3.56991494675047e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30030.Haematocrit percentage,42518,-0.0387252394658657,0.00653193839138464,-0.0515278387129795,-0.0259226402187518,3.07884024255425e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30040.Mean corpuscular volume,42518,-0.0498156478881437,0.00546327326058398,-0.0605236634788883,-0.0391076322973991,7.95674036597059e-20
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,42517,-0.0604549562383151,0.00547582513654141,-0.0711875735059363,-0.0497223389706939,2.66743462293888e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,42517,-0.0358990856712289,0.00536389791724114,-0.0464123255890215,-0.0253858457534363,2.21769084772396e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,42518,0.0178075019389144,0.00534040794212655,0.00734030237234637,0.0282747015054825,0.000855310363868001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30080.Platelet count,42518,0.356309210457457,0.0051942275785347,0.346128524403529,0.366489896511385,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30090.Platelet crit,42518,0.295437310118279,0.00541256901884106,0.284828674841351,0.306045945395208,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,42518,-0.201930111576775,0.00515531872670729,-0.212034536281121,-0.191825686872428,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30110.Platelet distribution width,42518,-0.0959482388071533,0.00530251111890049,-0.106341160600198,-0.0855553170141084,6.57527352970349e-73
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30120.Lymphocyte count,42453,0.0737879947081365,0.00542951113280436,0.06314615288784,0.0844298365284331,5.60815704393117e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30130.Monocyte count,42453,0.0371114052198103,0.00550801405956206,0.0263156976630686,0.0479071127765519,1.62951667573152e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30140.Neutrophill count,42453,0.0612829955508465,0.00547046006781939,0.0505608938179205,0.0720050972837725,4.35333366940004e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30150.Eosinophill count,42453,0.0509443067228422,0.00531588614988482,0.040525169869068,0.0613634435766165,9.87767298291299e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30160.Basophill count,42453,0.10443385976728,0.00914862936948885,0.086502546203082,0.122365173331478,3.88337542238668e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,42453,-0.013009372139011,0.0433295557208694,-0.097935301351915,0.0719165570738931,0.763993695007675
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30180.Lymphocyte percentage,42454,0.00876315767670223,0.00536377396698843,-0.00174983929859509,0.0192761546519995,0.102315171127978
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30190.Monocyte percentage,42454,-0.0235643615642649,0.00544066666356339,-0.0342280682248492,-0.0129006549036807,1.48670277730989e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30200.Neutrophill percentage,42454,-0.00507016588766538,0.0053122719039351,-0.0154822188193782,0.00534188704404742,0.339873918724532
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30210.Eosinophill percentage,42454,0.0254305671662109,0.00526552202508132,0.0151101439970515,0.0357509903353703,1.37257267901328e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30220.Basophill percentage,42454,-0.0207400525940609,0.00526487231079985,-0.0310592023232286,-0.0104209028648932,8.1841176960743e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,42453,-0.0126408141222373,0.0433488364234047,-0.0976045335121105,0.0723229052676359,0.770588724769275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30240.Reticulocyte percentage,41735,0.0280168603630445,0.00567310430346643,0.0168975759282503,0.0391361447978387,7.90127444559863e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30250.Reticulocyte count,41735,0.0282161644414217,0.00580015217476503,0.0168478661788822,0.0395844627039612,1.15031383357077e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,41735,-0.0467204678710603,0.00539423142290902,-0.0572931614599619,-0.0361477742821586,4.83284211716735e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30270.Mean sphered cell volume,41735,-0.0325564395934559,0.00544212621896394,-0.0432230069826252,-0.0218898722042865,2.21794586838375e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,41735,0.000770180130782505,0.00566397074546235,-0.0103312025303237,0.0118715627918887,0.891838670579552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,41735,0.0198483492272776,0.00579169979393763,0.00849661763115983,0.0312000808233953,0.000610802082161927
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,41735,0.0195654671674979,0.0058819563570493,0.00803683270768128,0.0310941016273145,0.00088066142854229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30500.Microalbumin in urine,13800,0.00169433918868352,0.00942605079722589,-0.0167807203738792,0.0201693987512463,0.857350933961752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,42599,-0.00340864435810082,0.00574157922037283,-0.0146621396300316,0.00784485091382993,0.552731225650331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30520.Potassium in urine,42519,-0.00571141057062323,0.00534622976667705,-0.0161900209133102,0.00476719977206378,0.285388465927933
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30530.Sodium in urine,42499,0.00156487192739143,0.00558460675166498,-0.00938095730587193,0.0125107011606548,0.779316485905412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30600.Albumin,38278,0.0598984064529647,0.00574445376164583,0.0486392770801389,0.0711575358257906,2.01571031060417e-25
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30610.Alkaline phosphatase,41775,0.0335138796265557,0.00551570954299721,0.0227030889222812,0.0443246703308303,1.24220448435024e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30620.Alanine aminotransferase,41769,0.01982075815596,0.00583139928367188,0.00839121555996316,0.0312503007519569,0.000677030371148723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30630.Apolipoprotein A,38025,-0.0226130754915569,0.00632845201486057,-0.0350168414406836,-0.0102093095424301,0.000353027878212742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30640.Apolipoprotein B,41542,0.109692528804701,0.00531032499860507,0.0992842918074354,0.120100765801967,2.54929029251683e-94
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,41650,-0.000488419486843085,0.0055280555312679,-0.0113234083281282,0.010346569354442,0.929596656156854
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30660.Direct bilirubin,35411,-0.0631674155113947,0.00598648498733928,-0.0749009260865797,-0.0514339049362098,5.45431454635217e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30670.Urea,41762,-0.0103383529108881,0.00567911565212617,-0.0214694195890554,0.000792713767279195,0.068702836193637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30680.Calcium,38270,0.0928752149164043,0.00556848897454823,0.0819609765262897,0.103789453306519,3.1079805187544e-62
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30690.Cholesterol,41788,0.11067787140384,0.00539486175788793,0.100103942358379,0.1212518004493,4.51702058061789e-93
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30700.Creatinine,41774,-0.023625882233482,0.00667141173279869,-0.0367018492297674,-0.0105499152371965,0.000398500741958085
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30710.C-reactive protein,41658,0.0176590975577274,0.0059589050294338,0.00597964370003716,0.0293385514154176,0.00304353576520781
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30720.Cystatin C,41791,0.0092362107569893,0.00632194144362715,-0.00315479447251991,0.0216272159864985,0.144029286595894
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,41773,0.0474717821313889,0.00594580106870373,0.0358180120367296,0.0591255522260482,1.45160745358556e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30740.Glucose,38228,0.0260071386227497,0.00574342022384809,0.0147500349840075,0.037264242261492,5.96784317721156e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),41607,0.0268062643578428,0.00579199910721346,0.0154539461077045,0.0381585826079812,3.70051597182511e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30760.HDL cholesterol,38248,-0.0511602792623921,0.00658003336223648,-0.0640571446523756,-0.0382634138724086,7.72823656129878e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30770.IGF-1,41568,-0.010454406519941,0.00559557927748567,-0.0214217419038129,0.000512928863930898,0.0617226736340934
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30780.LDL direct,41696,0.110896959031059,0.00531384000666504,0.100481832617996,0.121312085444123,3.15732752115386e-96
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30790.Lipoprotein A,33445,0.00164246576252234,0.00594837057296344,-0.010016340560486,0.0133012720855307,0.782457389704456
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30810.Phosphate,38189,0.0576693432555418,0.00575957331343813,0.0463805795612031,0.0689581069498806,1.43217374605962e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30830.SHBG,37921,-0.0662847078284192,0.00663753843944286,-0.0792942831697272,-0.0532751324871112,1.87004509515633e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30840.Total bilirubin,41628,-0.0693448698942816,0.00566519583163296,-0.0804486537242822,-0.058241086064281,2.16432951167552e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30850.Testosterone,37734,-0.0231305397605929,0.00928491756829891,-0.0413289781944588,-0.00493210132672708,0.0127356881171969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30860.Total protein,38244,0.118625927273542,0.00564468127024718,0.107562351983858,0.129689502563227,1.68690798269763e-97
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30870.Triglycerides,41761,0.178754969688953,0.00573424598988108,0.167515847548786,0.18999409182912,6.51629893372026e-211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30880.Urate,41728,0.0141608509088836,0.00672302811797624,0.000983715797650166,0.027337986020117,0.0351824926778071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30890.Vitamin D,39888,-0.0508790751888285,0.00601309090841082,-0.0626647333693137,-0.0390934170083433,2.73083529379176e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3137.Number of measurements made,39704,0.000981594255446187,0.0105332558351337,-0.019663587181416,0.0216267756923083,0.925753078166918
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3143.Ankle spacing width,24726,-0.0098103249671473,0.00964056223339208,-0.0287058269445958,0.00908517701030117,0.308873668698172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",24725,-0.0088753784551744,0.00741344846917897,-0.0234057374547652,0.00565498054441638,0.231240202205895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3146.Speed of sound through heel,24726,-0.0207765406138654,0.00718488303791976,-0.0348589113681881,-0.00669416985954262,0.00383495248328614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",24726,-0.0175031795423013,0.0072545494438405,-0.0317220964522286,-0.00328426263237388,0.0158413130468497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3148.Heel bone mineral density (BMD),24705,-0.0174513331506047,0.00727149855050392,-0.0317034703095924,-0.00319919599161707,0.0164040525838915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X3526.Mother's age at death,26158,-0.005705562,0.006964631,-0.01935624,0.007945114,0.4126686
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X3581.Age at menopause (last menstrual period),13591,-0.00162763060569554,0.00956172987672496,-0.0203686211640765,0.0171133599526854,0.864836949993781
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",8627,-0.014536640207014,0.0124483415530862,-0.0389353896510629,0.00986210923703486,0.24293705024315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4100.Ankle spacing width (left),14282,-0.00763768317846068,0.0126576338255133,-0.0324466454764667,0.0171712791195454,0.546248697420025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),14279,-0.00838973942061899,0.00970948721145084,-0.0274203343550626,0.0106408555138247,0.387560413473692
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4103.Speed of sound through heel (left),14282,-0.00928947084054424,0.00941566050096196,-0.0277441654224297,0.00916522374134121,0.323856531960276
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",14282,-0.00942233176658835,0.00950649756938601,-0.0280550670025849,0.00921040346940824,0.321630859227204
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),14274,-0.0095273171357754,0.00950354227605975,-0.0281542599968525,0.00909962572530171,0.316118364225199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",14282,-0.00943323674121217,0.00950652253865944,-0.0280660209169847,0.00919954743456034,0.321072420582459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4119.Ankle spacing width (right),14268,0.00631014449348408,0.0124829437057591,-0.0181564251698038,0.030776714156772,0.61321458938798
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),14267,0.000588386071467128,0.00975325627349564,-0.0185279962245843,0.0197047683675186,0.951895931307819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4122.Speed of sound through heel (right),14268,-0.00173523316230042,0.00942029655436639,-0.0201990144088585,0.0167285480842577,0.853857969262575
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",14268,-0.00101068841503325,0.00952623130541142,-0.0196821017736396,0.0176607249435731,0.915508229232612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),14257,0.000153908374166066,0.0095294781417014,-0.0185238687835687,0.0188316855319008,0.987114339373091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",14268,-0.00101415677486437,0.00952626315752181,-0.0196856325636071,0.0176573190138784,0.915219654803501
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4194.Pulse rate,14850,0.0309165309474812,0.0091044507251988,0.0130718075260915,0.0487612543688708,0.000686177258107152
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4195.Pulse wave reflection index,14850,-0.011726456254072,0.00927327854425475,-0.0299020822008113,0.00644916969266729,0.206055185772465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4196.Pulse wave peak to peak time,14839,-0.00441210553169848,0.009233833322609,-0.0225104188440121,0.0136862077806152,0.632785732665475
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4198.Position of the pulse wave peak,14850,0.00179439410556991,0.00933068827758562,-0.0164937549184979,0.0200825431296377,0.847501225158183
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4199.Position of pulse wave notch,14850,0.0202029382742584,0.00904269576761666,0.00247925456972972,0.037926621978787,0.0254865911013446
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,14850,0.00227471268880454,0.00937575201689565,-0.0161017612643109,0.02065118664192,0.808305806302933
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4269.Number of triplets attempted (left),14559,-0.0366464466369185,0.0445563568431959,-0.123976906049582,0.0506840127757455,0.410820653823939
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4270.Volume level set by participant (left),14404,-0.0226430550999342,0.0141335151573411,-0.0503447448083227,0.00505863460845431,0.109159355381358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4276.Number of triplets attempted (right),14566,-0.114663949986134,0.0433780156802415,-0.199684860719407,-0.0296430392528608,0.00821744195674379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4277.Volume level set by participant (right),14400,0.00307987400729277,0.014023863780472,-0.0244068990024324,0.0305666470170179,0.826172838390324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4288.Time to answer,14878,0.040801559927982,0.0105892154193355,0.0200466977060844,0.0615564221498796,0.000117110338762197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4290.Duration screen displayed,14878,0.0127728696285683,0.00952075662243557,-0.00588781335140544,0.031433552608542,0.179752268396667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X46.Hand grip strength (left),43723,0.00136860629096141,0.00754947224700465,-0.0134283593131677,0.0161655718950905,0.856144697481627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X47.Hand grip strength (right),43722,0.00943326038965722,0.00749500856972763,-0.00525695640700894,0.0241234771863234,0.208179515402004
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X48.Waist circumference,43852,0.08945731,0.0116287,0.06666505,0.1122496,1.469463e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X4803.Tinnitus,14593,-0.0184358716315827,0.0166898433180805,-0.0511479645350204,0.0142762212718551,0.269344153649706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4825.Noisy workplace,14793,0.0326560043084603,0.0186604978077132,-0.00391857139465746,0.0692305800115781,0.0801378369983725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4836.Loud music exposure frequency,14699,0.00858559357650263,0.0237780103774876,-0.0380193067633731,0.0551904939163784,0.718050195940067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X49.Hip circumference,43843,-0.0160470345639265,0.00932031786968166,-0.0343148575885026,0.0022207884606495,0.0851262024176876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X50.Standing height,43806,-0.0208649180293855,0.00739502597187687,-0.0353591689342641,-0.00637066712450679,0.0047824127989508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X5057.Number of older siblings,13066,0.00658951045381151,0.0149607700007603,-0.0227335987476787,0.0359126196553017,0.659616610391577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X51.Seated height,43614,-0.0182661605458218,0.00688895848523908,-0.0317685191768904,-0.00476380191475317,0.00801610859235488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5181.Ever had eye surgery,10059,-0.0172064450374029,0.0349406355680781,-0.085690090750836,0.0512772006760303,0.622413460184605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),10035,0.017499520555905,0.0110159677159732,-0.00409177616740252,0.0390908172792125,0.11219141758824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),10033,0.0294202975018896,0.0111262915932823,0.00761276597905636,0.0512278290247229,0.0082008446586485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),9920,0.0238999160852312,0.01118524142616,0.0019768428899576,0.0458229892805048,0.0326438384410461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),9917,0.0308030233380901,0.0112656224097281,0.008722403415023,0.0528836432611572,0.00626337827946189
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5199.logMAR, initial (right)",9996,0.0248739234174675,0.0177606816871492,-0.00993701268934488,0.0596848595242799,0.16139323459166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5200.Final number of letters displayed (right),9996,-0.0647371160453503,0.122026026822412,-0.303908128617278,0.174433896526577,0.595763998170967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5201.logMAR, final (right)",9900,0.0107661726720803,0.0112113759493219,-0.0112081241885905,0.0327404695327511,0.336932746118055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5202.Number of rounds to result (right),9996,0.012182020106966,0.0167437431399345,-0.0206357164473056,0.0449997566612377,0.466902165173582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5206.logMAR, initial (left)",9992,-0.00389429109130603,0.0177487371613264,-0.0386818159275057,0.0308932337448937,0.826333384591901
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5207.Final number of letters displayed (left),9992,-0.0114741435683228,0.112227168260174,-0.231439393358264,0.208491106221618,0.918567965617361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5208.logMAR, final (left)",9901,-0.0104885888485014,0.0112182564682294,-0.0324763715262312,0.0114991938292283,0.349833228065968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5209.Number of rounds to result (left),9986,0.0295721644654674,0.0167699425947868,-0.00329692302031465,0.0624412519512494,0.077863224692297
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",9573,0.0108472991158917,0.0111305710447644,-0.0109686201318466,0.0326632183636299,0.329808137166615
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",9573,0.0143055614998212,0.0110719301480331,-0.00739542159032377,0.0360065445899662,0.196368745742684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5256.Corneal hysteresis (right),9573,0.00337568079253799,0.011201584056603,-0.018579423958404,0.02533078554348,0.763148492992926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5257.Corneal resistance factor (right),9573,0.00973350717795788,0.0111232541100849,-0.0120680708778085,0.0315350852337242,0.381563615761184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",9540,0.0204192066236263,0.0111667341723472,-0.00146759235417417,0.0423060056014268,0.067494610407823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",9540,0.0111860356412303,0.011056705274029,-0.0104851066958664,0.0328571779783271,0.311708642421581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5264.Corneal hysteresis (left),9540,-0.0124083289090662,0.0112436871729347,-0.0344459557680182,0.00962929794988585,0.269802451680503
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5265.Corneal resistance factor (left),9540,-0.00216948621194661,0.0111375405873022,-0.0239990657630589,0.0196600933391657,0.845561176136748
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,9933,0.0828357368557726,0.0791434605181346,-0.0722854457597712,0.237956919471316,0.295285175116725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",43727,-0.0213725054729433,0.0299555391531115,-0.0800853622130419,0.0373403512671553,0.47555615802851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",43727,-0.0687770560216143,0.0325551281433978,-0.132585107182674,-0.00496900486055467,0.0346377988499354
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",43727,-0.0718607676039576,0.0312088070310348,-0.133030029384786,-0.0106915058231293,0.0213071725853534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",43727,-0.0599016432963531,0.0133461005718904,-0.0860600004172583,-0.0337432861754479,7.19682325732111e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",43727,0.0550951652749423,0.0122887670947188,0.0310091817692935,0.0791811487805912,7.36577997358356e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",19747,-0.00405484474531614,0.0155505888123019,-0.0345339988174278,0.0264243093267955,0.79428660194694
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",19747,-0.0280034411481896,0.0416292534978972,-0.109596778004068,0.0535898957076888,0.501154568861859
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",19747,-0.0220081363261398,0.0301947606848423,-0.0811898672684306,0.0371735946161511,0.466088194233691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",19747,0.0121706238440883,0.0184101124435781,-0.0239131965453249,0.0482544442335014,0.508566404954935
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,43857,0.0165210013679993,0.0205277815800941,-0.0237134505289852,0.0567554532649839,0.42093264072419
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,43857,-0.0691069274326234,0.0262580308485593,-0.1205726678958,-0.0176411869694472,0.00849536621564759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),43857,-0.0180307296459708,0.0203191381273176,-0.0578562403755133,0.0217947810835718,0.374880993795674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',43857,-0.0848251706644139,0.033102584477301,-0.149706236239924,-0.0199441050889039,0.0103956503752191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),43857,0.0184371884097783,0.0813503996397273,-0.141009594884087,0.177883971703644,0.820705375104334
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),43857,0.0193018420772518,0.0561250261838165,-0.0907032092430286,0.129306893397532,0.730917170486481
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,43857,0.228669158734319,0.0877080910061608,0.0567613003622437,0.400577017106394,0.00913271975287059
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,43726,0.00393267513052208,0.0171124646107567,-0.029607755506561,0.0374731057676052,0.818237780897125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,43726,0.0408508714843892,0.0290930934300072,-0.016171591638425,0.0978733346072034,0.160283294200267
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,43726,0.00981539899701966,0.0153421223970615,-0.020255160901221,0.0398859588952603,0.522326790914981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,43726,0.0201574617700076,0.0255511851297721,-0.0299228610843457,0.0702377846243609,0.430171718798952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,43726,0.0261401625652187,0.0253998563209631,-0.0236435558238689,0.0759238809543064,0.303416729850384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,43726,0.0154583957155342,0.0142944826360661,-0.0125587902511553,0.0434755816822237,0.279514543737896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,13519,-0.106524371448253,0.0341529957251842,-0.173464243069614,-0.0395844998268917,0.00181826408719653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,13519,-0.086181290336994,0.0293274787282677,-0.143663148644399,-0.0286994320295894,0.00330271951536283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,13519,0.0541391400740458,0.0403100362582069,-0.0248685309920397,0.133146811140131,0.179272363060451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,13519,0.0621740186754097,0.0320585994266646,-0.000660836200852874,0.125008873551672,0.0524750778402955
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,43675,-0.0244502986069622,0.0433709825579322,-0.109457424420509,0.0605568272065849,0.572928636086523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,43675,0.0556626385630184,0.0654845458723582,-0.0726870713468037,0.184012348472841,0.39532317110752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,43675,-0.0313435931776842,0.11490658231224,-0.256560494509675,0.193873308154307,0.78502780143757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,43675,0.00645430103622013,0.109459615074505,-0.20808654450981,0.220995146582251,0.952980147458381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,43675,-0.0528034394861923,0.0375347297435987,-0.126371509783646,0.0207646308112612,0.159497126071744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,43675,0.137237061958657,0.0503131031275648,0.0386233798286295,0.235850744088684,0.00638107162109094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,43675,0.00450864612575729,0.023214367572561,-0.0409915143164623,0.0500088065679768,0.846006157434619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",14182,0.0573855843947105,0.037637871598236,-0.0163846439378322,0.131155812727253,0.12736208608257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",14182,-0.0392463971286538,0.0398041477421993,-0.117262526703364,0.0387697324460567,0.324156022550026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",14182,0.0133850270134552,0.0547758601355224,-0.0939756588521688,0.120745712879079,0.806955587396836
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",14182,0.0253124705374444,0.0192329252293154,-0.0123840629120138,0.0630090039869027,0.188161465664647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",19861,-0.0625181531381595,0.0177731335676458,-0.0973534949307453,-0.0276828113455738,0.000436498712304842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",19861,0.0201520088859948,0.0172953295643961,-0.0137468370602216,0.0540508548322112,0.243963962251024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",19861,0.0596375609351465,0.0158496771066926,0.0285721938060291,0.0907029280642639,0.000168573101846728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",19862,-0.00927203539597532,0.0375869970385005,-0.0829425495914362,0.0643984787994856,0.805156893498969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",19862,0.00924686610519284,0.0223789011697336,-0.034615780187485,0.0531095123978707,0.679467689898036
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",19862,-0.0118629503931807,0.0303705332543212,-0.0713891955716502,0.0476632947852887,0.696091760019336
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,43726,-0.00708043168099865,0.0357741487126655,-0.077197763157823,0.0630368997958257,0.843108310188095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,43726,0.0221621452018899,0.0250696991127414,-0.0269744650590834,0.0712987554628631,0.376689637142881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,43726,-0.142166908657504,0.0721875855388265,-0.283654576313604,-0.000679241001404374,0.0489124036423201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,43726,-0.0288959507945623,0.0256948771058924,-0.0792579099221113,0.0214660083329868,0.26077313059401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,43726,0.0319934114583083,0.0292781385396557,-0.025391740079417,0.0893785629960335,0.274513718884174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),43726,-0.0425538663489834,0.0336928502727958,-0.108591852883663,0.0234841201856964,0.206598087677742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,43726,-0.0206973279931686,0.0111384181525551,-0.0425286275721766,0.00113397158583954,0.0631483633173969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,8555,-0.0165344321759434,0.0317568463009351,-0.0787778509257762,0.0457089865738893,0.602619058516294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,8555,-0.026391574053306,0.0399649265601697,-0.104722830111239,0.0519396820046267,0.509035263324252
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,8555,-0.0211971888791788,0.0283168434652475,-0.0766982020710639,0.0343038243127062,0.454135981307845
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,8555,0.0116442776226115,0.0253846638599667,-0.0381096635429232,0.0613982187881462,0.646451884105468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,43920,0.0418971165922425,0.0130299486952631,0.0163584171495268,0.0674358160349581,0.00130335517104772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,43920,0.0833957118869883,0.037583161209251,0.00973271591685626,0.15705870785712,0.0264942116650083
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,43920,0.0164084054840763,0.0122015324487368,-0.00750659811544788,0.0403234090836004,0.178702478190443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,43920,-0.0236073134346806,0.0118090961918702,-0.0467531419707462,-0.000461484898615076,0.0456059847835163
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,43920,0.0332611263690081,0.018334086610719,-0.00267368338800104,0.0691959361260172,0.0696585773045459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,43920,0.00198757036985503,0.0162649933885926,-0.0298918166717865,0.0338669574114966,0.902741761350813
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,43920,-0.00304953432978654,0.0127051926774128,-0.0279517119775156,0.0218526433179426,0.810313798952878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,43920,0.061159755085009,0.0371072123709509,-0.0115703811620548,0.133889891332073,0.0993207397690848
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,30408,-0.016706818336481,0.012874136761521,-0.0419401263890622,0.00852648971610013,0.194398928724761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,30408,-0.00394666354644489,0.0134539273898158,-0.0303163612304839,0.0224230341375941,0.769259258232542
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,30408,0.0107028338454977,0.0151390121458441,-0.0189696299603567,0.0403752976513521,0.479590277225811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,30409,0.0102941246130308,0.0206725243076355,-0.0302240230299348,0.0508122722559965,0.618514665326482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,30409,0.00667620095526665,0.0136027182191728,-0.019985126754312,0.0333375286648453,0.623572136939873
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,43525,-0.00178846286874405,0.0131311984414273,-0.0275256118139415,0.0239486860764534,0.89166418808861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,43525,0.0127767460296233,0.0104747119248904,-0.00775368934316182,0.0333071814024085,0.222558447181694
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,43525,0.0105625927186863,0.0116116172932887,-0.0121961771761595,0.0333213626135322,0.363008295653652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,43525,0.0371421141827873,0.0210513843881262,-0.00411859921794015,0.0784028275835147,0.0776792537718245
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),43554,0.0126539290536379,0.0115568892340909,-0.00999757384518017,0.035305431952456,0.273555472296016
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,43554,-0.0188681052895523,0.0180972189026794,-0.0543386543388039,0.0166024437596993,0.297140789763851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),43726,0.0232039935650619,0.0113828569051563,0.000893594030955451,0.0455143930991683,0.0415056107473201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,43726,0.0239511160213505,0.0134807934846316,-0.00247123920852749,0.0503734712512285,0.0756271269694095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,43726,-0.0276567848737094,0.0201988607144105,-0.067246551873954,0.0119329821265352,0.170935991356587
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,43726,0.0296153497085116,0.025987489527054,-0.0213201297645142,0.0805508291815374,0.254459123374846
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,43726,0.0135196282853888,0.0281474749542298,-0.0416494226249017,0.0686886791956792,0.631006488497489
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,43726,0.0195548877608394,0.0334585165374311,-0.0460238046525256,0.0851335801742044,0.558919450428036
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",24726,-0.0175110469321928,0.00725455885107914,-0.0317299822803079,-0.00329211158407765,0.015794391426174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,42981,-0.00845564583943261,0.00820123138510468,-0.0245300593542378,0.00761876767537255,0.302536544394058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X874.Duration of walks,37199,-0.00864144207710466,0.00562802817415817,-0.0196723772984547,0.00238949314424536,0.124686800659754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,41523,0.0145251201432124,0.00793539102094054,-0.00102824625783107,0.0300784865442558,0.0671939176725416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X894.Duration of moderate activity,32167,0.000378819789213974,0.00958676968539288,-0.0184112487941561,0.019168888372584,0.968480157594246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,8978,0.0174622213504057,0.0123636750504999,-0.00677058174857402,0.0416950244493855,0.157872484511963
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,41485,0.00625060662437403,0.00811726447987882,-0.00965923175618846,0.0221604450049365,0.44128140846121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X914.Duration of vigorous activity,23218,9.61203758395734e-05,0.00717507317902413,-0.0139670230550477,0.0141592638067269,0.989311629065412
